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Overview 
This thesis focuses on interventions for people with dementia and their carers. 
Part 1 of the thesis is a literature review examining the effectiveness of combined 
intervention programmes for people with dementia and their carers. A previous 
review examined literature published before 2005 and current review sought to 
update this review. The 18 papers retrieved from the review are presented according 
to the type of intervention they describe. The effectiveness of each type intervention 
was discussed followed by a consideration of the effectiveness of interventions for 
people with dementia and their carers according to different outcomes. 
Part 2 is an empirical study using a randomized controlled trial to assess the 
effectiveness of weekly Cognitive Stimulation Therapy (CST) and the additional 
effects of enhancing CST with a carer training program. Quantitative outcomes for 
people with dementia are reported. This paper forms part of a joint research study 
conducted with Jacobi (2013; Counselling Doctorate Trainee, City University) who 
will report quantitative outcomes for carers and evaluate the carer training program 
using a qualitative approach.  
Part 3 is a critical appraisal and discusses the factors that should be taken into 
account when interpreting non-significant research findings. A discussion of the 
ethical obligations of publishing non-significant research findings is also presented. 
Finally, the quality of the research study described in Part 2 is assessed. 
Consideration is given to the strengths and weaknesses of the research and a quality 
rating, using a formal assessment scale, is undertaken. 
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Abstract 
Background: Receiving a diagnosis of dementia can have a profound effect on both 
the person with dementia and their carers. Developing interventions to support both 
groups are therefore essential.  This review aims to determine the effectiveness of 
combined intervention programmes for people with dementia and their informal 
carers. 
Method: A systematic review was conducted to identify studies published between 
February 2005 and March 2013 which included combined intervention programmes 
for people with dementia and their carers. 18 studies were found to meet inclusion 
criteria and included in the final review. Scoring criteria were used to rate the quality 
of each study. 
Results: The 18 papers were categorised according to the type of intervention 
offered. These were: psychotherapeutic, psychosocial, support group, rehabilitation 
or case management interventions. Functional rehabilitation and case management 
interventions appear to be most effective, whilst less conclusive evidence for other 
categories of interventions was found. No consistent pattern between type of 
intervention and outcomes observed was noted.  
Discussion: Combined interventions for people with dementia and their carers may 
have positive outcomes for both but interventions are not consistently effective. The 
mixed outcomes reported and variability in the quality of the studies means that 
definitive conclusions are difficult to draw and further research is required. 
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Dementia is a progressive, chronic neurodegenerative disorder characterised 
by widespread decline in cognitive functioning. Specific impairments include 
memory loss, in particular problems with short-term memory, language impairment, 
changes in personality and mood, disorientation, difficulty concentrating, impaired 
reasoning abilities, difficulties with activities of daily living and self-neglect. People 
with dementia have high levels of care needs, particularly as their condition 
deteriorates and a high proportion of these needs are met by informal or family carers. 
In 2010 the number of people living with dementia worldwide was estimated at 35.6 
million. It is estimated that this will double by 2030 and more than triple to 115.4 
million by 2050 (World Alzheimer’s Report, 2010). As such dementia is now a 
major public health priority, with particular emphasis being placed on increasing 
knowledge and awareness of dementia, early detection and diagnosis and 
development of suitable interventions for people with dementia and their families 
(Department of Health, 2009).  
With these priorities in mind, much research has been focused on the 
development and evaluation of treatments for dementia, which has included both 
pharmacological and non-pharmacological interventions. Although pharmacological 
treatments can slow the progress of dementia for some people, they are limited in 
their effectiveness, can cause unpleasant and intolerable side effects and are not 
suitable for everyone. As such the need for non-pharmacological interventions, 
which offer greater choice, can be accessed by a wide range of people with dementia, 
are cost-effective and can also include carers, is increasingly important. Olazaran et 
al. (2010) define non-pharmacological interventions as “any theoretically based, 
nonchemical, focused and replicable intervention, conducted with the patient or the 
caregiver (CG), which potentially provides some relevant benefit” (p.162).  
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Non-Pharmacological Interventions for People with Dementia 
Non-pharmacological interventions for people with dementia include 
treatments for cognitive, behavioural and emotional symptoms. A wide variety of 
interventions have been developed, including cognitive stimulation (Breuil et al., 
1994; Spector et al., 2003), reality orientation (Onder et al., 2005), music therapy 
(Guetin et al., 2009), multisensory stimulation (Milev et al., 2008) and 
multicomponent treatments (Teri, Gibbons, McCurry & Logsdon et al., 2003). 
Interventions have aimed to improve or slow the rate of deterioration of cognition, 
mood, behaviour, physical activity, quality of life, activities of daily living or a 
combination of these. It is important to note that positive outcomes following an 
intervention for people with a progressively deteriorating disorder such as dementia 
may include changes in outcome measures from baseline but also a slower rate of 
deterioration in outcomes than would be expected.  
Olazaran et al. (2010) conducted a systematic literature review and meta-
analysis of all available randomised controlled trials to determine the efficacy of 
non-pharmacological interventions for people with dementia. Cognitive stimulation 
groups, cognitive training, behavioural interventions and activities of daily living 
training all resulted in positive outcomes for people with dementia. Multicomponent 
interventions demonstrated the most diverse benefits including improvements in the 
cognition, behaviour (general behaviour and withdrawal), mood, orientation and 
performance of activities of daily living.  No recommendations were found for 
electrical stimulation, physical exercise, use of music, reminiscence, massage and 
touch, recreation therapy, use of light, multisensory stimulation, support and 
psychotherapy, validation therapy, case management or respite care. However, lack 
of evidence may reflect a paucity of studies, lack of adequate outcome measures and 
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poor study designs. When included as part of multicomponent interventions 
reminiscence, physical exercise, support and relaxation were found to result in 
positive outcomes for people with dementia. 
It appears that despite the wide range of non-pharmacological interventions 
available for people with dementia, there is a lack of evidence to support the efficacy 
of many of these at present. However, as stated, some interventions do result in 
positive outcomes. Olazaran et al. (2010) conclude that such therapies “can make 
both a realistic and affordable contribution to the improvement and provision of care 
for people with Alzheimer’s disease and related dementias” (p.172). 
Impact of Caregiving 
Caregiving is described by Shultz and Martire (2004) as: 
… the provision of extraordinary care, exceeding the bounds of what 
is normative or usual in family relationships. Caregiving typically 
involves a significant expenditure of time, energy, and money over 
potentially long periods of time; it involves tasks that may be 
unpleasant and uncomfortable and are psychologically stressful and 
physically exhausting (p.240). 
As a long term and often unpredictable condition, dementia not only imposes a 
significant impact on the life of the person with dementia but also on those involved 
in their care. Informal carers (most frequently family members), defined by Brodaty, 
Green and Koschera, (2003) as “persons providing unpaid care, at home or in a non-
institutional environment” (p.657), commit time, energy, money and effort to caring. 
However, caregiving is associated with higher levels of depression, anxiety and 
psychotropic drug use. Up to half of dementia carers report experiencing high levels 
of depression and over 80% report that they frequently feel stressed (Alzheimer’s 
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Association, 2006). Caregiving is also associated with decreased quality of life, 
diminished self-efficacy, lower life satisfaction and poorer health outcomes, such as 
obesity (Vitaliano et al. 2005) and compromised immune systems (Kiecolt-Glaser, 
Dura, Speicher, Trask & Glaser, 1991). Brodaty and Dunkin (2009) report that carers 
are also at increased risk of experiencing social isolation due to lack of social contact 
and a concurrent reduction in social support and of experiencing financial strain due 
to cutting back on working hours. Kasuya, Polgar-Bailey and Takeuchi (2000) define 
these negative consequences of caregiving as ‘caregiver burden’. 
Given the huge impact caregiving can have it is essential that the needs of 
carers are met as well as the needs of the person they are caring for. In addition to the 
impact on the carer, high levels of caregiver burden can also result in poorer 
outcomes for people with dementia, including decreased quality of life and early 
admission to institutional settings (Etters, Goodall & Harrison, 2008). This evidence 
serves to strengthen the need to provide suitable and effective interventions for carers 
of people with dementia. 
Non-Pharmacological Interventions for Carers 
A number of interventions to support the carers of people with dementia have 
been evaluated, including individual or group psychoeducation, peer support groups, 
psychotherapy and multicomponent interventions. Outcomes of research into the 
effectiveness of such interventions are mixed. Broadaty et al. (2003) found no 
evidence to support the efficacy of short education programmes, support groups, 
single interviews or brief interventions, whilst evidence for the effectiveness of 
cognitive behavioural therapy is mixed. However, Olazaran et al. (2010) reported 
that carer education, use of electronic devices and multicomponent interventions, 
such as long term counselling and support, led to positive outcomes. In addition, 
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Etters et al. (2008) reported that both multicomponent interventions and 
psychoeducation plus role-play training led to a reduction in carer burden. These 
authors state that offering tailored interventions which respond to individual carer 
needs, can improve outcomes for both carers and people with dementia, including 
delayed admission to nursing or care homes. Despite the mixed outcome of research 
studies, a number of interventions for carers of people with dementia do have 
demonstrable positive outcomes for both carers and the people they care for. 
Combined Interventions 
Given that the effects of dementia on both people with dementia and their 
carers can be great and can interact with each other, providing effective interventions 
may result in improved outcomes for both. Alongside individual interventions, the 
value of designing combined interventions has also been recognised (Brodaty et al., 
2003). These authors note that a key feature of successful carer interventions was the 
involvement of people with dementia alongside their carers in structured 
programmes. Dröes, Meiland, Schmitz and van Tilburg (2006) point out that given 
the complex and diverse range of problems experienced by people with dementia and 
their carers, single interventions simply do not met their needs. Interventions which 
include both can have a greater impact than interventions which target each alone.  
Combined interventions are designed to meet the needs of both the person 
with dementia and their carer, either by including both in the same intervention or by 
offering separate interventions to run concurrently and complement each other. Such 
interventions can be more cost-effective and more convenient for families. They take 
a holistic approach to treatment and provide scope for tailoring treatment to 
individual family needs. Interventions which include both the person with dementia 
and their carer include family counselling, occupational therapy, case management, 
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and support group programmes. Combined programmes in which people with 
dementia and their carers receive separate interventions are varied, but include drug 
treatment and cognitive stimulation for people with dementia and support groups for 
carers and memory training plus music therapy for people with dementia and support 
groups for carers.   
Existing Review of Combined Interventions 
One previous systematic review has examined the effects of combined 
intervention programmes for people with dementia and their carers. Smits et al. 
(2007) reviewed 22 interventions in 25 reports published between January 1992 and 
February 2005. Outcomes for people with dementia reported in the review were: 
mental health, cognitive functioning, behavioural problems, physical functioning, 
delayed admission to long-stay care and mortality. Depressive symptoms were found 
to improve in people with dementia following participation in combined 
interventions and time to admission to long-stay care units was delayed. Evidence for 
the remaining outcomes was mixed. The authors classified outcomes for carers into 
three groups: mental health, burden and competence. Only carer general mental 
health was found to be significantly improved following combined intervention 
programmes. Results for carer burden and other areas of mental health were 
inconclusive, whilst competence appeared to improve in some carers but not others.  
Only 18 of the 22 studies reported outcomes for both people with dementia 
and their carers and of these 10 reported at least some positive results for both, 
suggesting that some types of combined interventions are effective for both people 
with dementia and their carers. However, no discussion of the types of interventions 
which may be most effective was included. The authors also point out that the review 
was limited by the lack of sufficient power of many of the included studies, the 
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varying degree of quality of the studies and the limited number of studies available, 
although it should be noted that only three databases were searched.  
Although combined interventions appear to delay time until admission to 
institutional care and improve aspects of both people with dementia and carer mental 
health, Smits et al. (2007) were unable to make specific recommendations for the 
development and implementation of intervention programmes because of the 
inconclusive nature of the results for the remaining outcomes reported. 
The Current Review 
This review aims to update the previous review conducted by Smits et al. 
(2007) by examining literature published since February 2005 in order to examine 
the most recent literature. The review will seek to determine whether clear positive 
effects of combined intervention programmes for people with dementia and their 
carers can be established. A more detailed evaluation of the effectiveness of specific 
types of combined interventions will be included. 
Literature Review Questions 
The following questions will be addressed in this literature review: 
1. What effects do combined intervention programmes for people with 
dementia and their carers a) have on people with dementia, and b) have 
on their carers? 
2. Can combined intervention programmes result in positive outcomes for 
both the people with dementia and their carers who participate? 
Method 
The review followed the recommendations made by Petticrew and Gilbody 
(2004) for planning and conducting systematic literature reviews. In order to include 
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only studies published since Smits et al.’s (2007) systematic review the search was 
limited to studies published between February 2005 and March 2013.  
Inclusion Criteria 
 Randomised controlled trials (RCTs) and quasi-experimental designs 
 Studies which evaluate the effectiveness of one or more combined, 
non-drug intervention programme for people with dementia and their 
carers 
 Studies which report one or more quantitative, psychological outcome 
for people with dementia and/or their carers 
 Studies which include only  informal carers providing care at home or 
in non-institutional environments 
 Studies published in English in peer reviewed journals 
Exclusion Criteria 
 Interventions for either people with dementia or carers alone 
 Studies which include pharmacological interventions 
 Studies which include herbal remedy/vitamin supplement 
interventions 
 Studies investigating carer-led interventions in which carers receive 
no intervention themselves 
 Thesis dissertations, policy guidelines, case study designs and 
qualitative studies 
Search Strategy 
Systematic searches of the PsycInfo, PubMed, Medline, Embase and 
CINAHL electronic databases were conducted separately, with all searches limited to 
results in English, including human subjects and published between February 2005 
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and March 2013. Keywords entered were identical for each database and were 
chosen to identify results involving combined (combined, joint, integrated) 
intervention programmes (intervention*, therap*, treatment*, psychotherapy*, 
counsel?ing, support, programme*, training) for people with dementia (dementia, 
Alzheimer’s disease) and their carers (caregive*. Carer*, family member). The terms 
‘combined’, ‘intervention’, ‘dementia’ and ‘carer’ were entered into subject heading 
or thesaurus searches to include any related synonyms not already identified. Terms 
in italics were added to the list of search terms after consulting the search terms used 
by Smits et al. (2007) in their review of the same subject area. The wildcard symbol 
was used where there were variations in spellings, such as counselling or counseling 
and search terms were truncated  where plural or other forms of the word were 
relevant, for example therapy and therapies; carer and carers.  
The titles and abstract of all papers were screened for relevance, with further 
examination of papers conducted wherever necessary to determine whether they met 
inclusion criteria. For those articles which met the inclusion criteria, a reference list 
search was conducted to identify further articles. 
Evaluating the Quality of Studies 
Oxman and Guyatt (1988) cite assessment of the quality, or validity, of 
studies as a key component of systematic reviews of the literature. In order to 
provide a structured assessment of the quality of each study included in this review, 
several assessment tools were employed.  To assess the methodological quality of 
randomised controlled trials (RCTs) the scoring criteria developed by Jadad et al. 
(1996) was used (see Appendix A).  Petticrew and Gilbody (2004) highlight these 
criteria as one of the most widely used for RCTs. The Jadad Scale is both valid and 
reliable and allows the quality of different studies to be compared. These criteria 
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provide a rating of studies according to the quality of the randomisation and double-
blinding procedures used and the description of withdrawals and dropouts. A rating 
of between 0 and 5 is given to each study. However, in psychological research only 
single blinding is possible meaning that the Jadad Scale is limited when used with 
such research because to achieve a  maximum score of five a study will need to have 
employed a double-blind strategy.  Therefore, the maximum score studies in this 
review could achieve was four.  
For RCTs using cluster randomisation (cluster randomised controlled trials, 
CRCTs) CONSORT guidelines were consulted to assess the quality of these studies 
(Campbell, Elbourne and Altman, 2004). CRCTs do not randomise participants 
individually but in groups and the CONSORT guidelines allow the specific 
procedural requirements of CRCTs to be reviewed.  
In order to assess the quality of non-randomised designs the York Centre for 
Systematic Reviews criteria was used (University of York, 2009). Studies are rated 
on eight criteria (see appendix B) including: adequacy of the description of 
participants and interventions, reliability, validity and suitability of outcome 
measures, dropout rates, follow-up procedures, matching or statistical control of 
groups and blinding of outcome assessors. Studies which met all criteria were rated 
as good, those which met more than half were rated as adequate and those which met 
less than half were rated as poor. 
Results 
Overview of Results 
The search strategy yielded 329 results, of which 14 studies met inclusion 
criteria and were included in the final review. Of the remaining papers 185 were 
excluded because they were not relevant to the current review, 43 did not include an 
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intervention, 28 included carers only, 25 included people with dementia only, 12 
were either conducted in residential settings or involved formal carers, 11 used 
pharmacological or herbal remedy/vitamin supplement interventions, 6 were 
conference abstracts, 4 were research protocols and 1 was a qualitative study. An 
additional four papers were included following the reference list search. 
Eighteen papers describing 17 interventions were included in the final review, 
as two papers described different outcomes from the same study. The 18 papers were 
categorised according to the type of intervention offered. The following groups were 
identified:  psychotherapeutic interventions (N=4); psychosocial interventions (N=3); 
support group programmes (N=2); rehabilitation including cognitive rehabilitation 
(N=2) and functional rehabilitation (N=3) and case management (N=4). Seven 
studies offered fully individualised interventions, whereby each dyad received 
interventions based on individual need and assessment. Six studies utilised a manual-
based or fixed programme intervention whereby all dyads received the same 
treatment. The remaining four studies were only partially individualised, either 
because they offered a combination of fixed and flexible components, or because the 
selections of modules from a manualised intervention were individualised. Details of 
the studies included in the review are summarised in Table 1. 
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Table 1 
Summary of studies examining the effectiveness of combined interventions 
Psychotherapeutic Interventions 
Authors Design, intervention, 
duration of intervention 
& level of 
individualisation 
N Intervention received Outcome measures 
and assessment 
points 
Results Quality Rating 
Bakker et 
al. (2011) 
RCT 
 
Psychotherapeutic nursing 
home programme  vs. 
usual care 
 
Duration: 13 weeks 
 
Fully individualised  
168 dyads PWD :Individualised package 
of integrative psychotherapeutic 
interventions including 
counselling, life review, CBT, 
IPT, BRT, rehabilitation, 
pyschoeduction, family therapy 
PWD: NPI, MMSE, 
BI, MOS Short-Form 
General 
Health Survey-20, 
EQ- 
5D, subjective health, 
Global Deterioration 
Scale  
PWD:  
 Sig. decrease in behavioural disturbance (NPI) as rated by 
carers but not staff at 3 and 6months in intervention group. 
 Sig. improvement in cognition (MMSE) between baseline 
and 3 months but not maintained at 6 months. 
 Sig. decrease in self-care (BI) in intervention group 
 No sig. change in quality of life(EQ-5) 
Jadad: 3/4 
 
Strengths: 6 month 
follow-up, adequate 
N, use of intention-to-
treat principle in 
analysis 
 
Weaknesses: 
assessors not blind, 
inclusion of 
participants  with 
DSM-IV diagnosis of 
dementia or amnesiac 
disorder or other 
cognitive impairment, 
low recruitment 
uptake numbers 
 
 
 
 
 
 
CG: Family therapy CG: N-EMD, CB, 
Caregiver 
Competence List 
 
Baseline, 3 and 6 
months 
CG:  
 Sig. greater reduction in CG burden (N-EMD, CB)  
 sig. greater increase in competence (Caregiver Competence 
List) at 3 and 6 months in intervention group 
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Paukert et 
al. (2010) 
One group time series 
design 
 
CBT for Anxiety  
 
Duration: 6 months 
 
Partially individualised 
(treatment manualised but 
selection of modules 
individualised) 
9 dyads PWD: no individual 
intervention (see both) 
PWD: NPI-Anxiety 
subscale, RAID, 
PSWQA, GAI, GDS, 
RMBCP, CSQ 
PWD:  
 Improvements (20% or more reduction from baseline score) 
in anxiety (86% and 66% showed reduction in NPI-A at 3 
and 6 months respectively, 25% and 57% showed 
improvements according to RAID at 3 and 6 months, 50% 
and 43% showed improvements according to PSWQA at 3 
and 6 months, 38% and 43% showed improvements 
according to GAI at 3 and 6 months respectively) 
 75% and 57% showed a decrease in depressive symptoms 
(GDS) at 3 and 6 months respectively 
 1 participant showed improvement in behaviour (RMBCP) at 
each time point 
 Average satisfaction at 6 months was 28.8/34 
York= Poor 
 
Strengths: use of 
relevant outcome 
measures 
 
Weaknesses lacks 
internal validity due 
to lack of control 
group,  small N, no 
power to detect sig. 
changes therefore 
only improvement 
(defined as 20% 
reduction in scores 
from baseline) 
reported, no follow-
up 
CG: psychoeducation, 
information re: communication 
skills and increasing self-care 
 
Both: 12 weekly CBT home-
based session, between session 
telephone check in, 8 telephone 
booster sessions 
CG: RMBCP, NPI-
Anxiety (distress 
question), CSQ 
 
Baseline, 3 and 6 
months 
CG:  
 71% and 50% reported decrease in distress over PWD 
anxiety (NPI=Anxiety) at 3 and 6 months respectively,  
 38% and 57% reported decreased distress over PWD 
problem behaviours (RMBCP) at 3 and 6 months 
 Average satisfaction at 6 months was 29.7/34 
Weber et 
al. (2009) 
One group time series 
design 
 
Psychotherapeutic day 
hospital programme 
 
Duration: mean = 9 
months (SD=7) 
 
Fixed programme 
76 dyads PWD: day hospital programme 
including group: music therapy, 
movement therapy, 
psychodynamic therapy and 
sociotherapy. Individual 
reviews 
PWD: CAS, SAS, 
GES, NPI 
PWD:   
 No sig. self-reported (CAS)  improvement in progress in 
therapeutic community treatment (inc. behaviour, attitude 
and cognitive change) but sig. increase in staff-reported 
ratings of progress (SAS) at all time points 
 Sig. progress made in groups (GES) across time  
 Sig. decrease in behavioural disturbance (NPI) at all time 
points 
York=Poor 
 
Strengths: analysis 
controlled for 
stressful life events 
and medication 
 
Weaknesses: lacks 
internal validity due 
to lack of control 
group, assessors not 
blind, no follow-up, 
variation in treatment 
duration across 
participants, no 
description of drop 
out, no description of 
CG participants 
CG: Family intervention 
including assessment of 
communication patterns, 
discussion of carer needs and 
relief from caregiver burnout 
CG: none recorded 
 
 
Baseline, 3, 6 and 12 
months, discharge 
CG: none recorded 
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Woods et 
al. (2012) 
RCT 
 
Reminiscence groups vs. 
care as usual 
 
Duration: 10 months 
 
Manualised intervention 
487 dyads Both: 12 weekly reminiscence 
groups followed by 7 monthly 
maintenance sessions 
PWD: QoL-AD 
(PWD & CG rated), 
AMI(E), QCPR, 
CSD, RAID, EQ-5D, 
Bristol Activities of 
Daily Living Scale, 
CSRI, use of day 
services 
PWD:  
 no sig. difference between the two groups on any primary or 
secondary measure: quality of life (QoL-AD, EQ-5D), 
autobiographical memory (AMI(E), depression (CSD), 
anxiety (RAID), activities of daily living (Bristol ADL 
Scale), quality of PWD-CG relationship (QCPR) at any time 
point 
 Sig. greater use of day care services in the intervention 
group. 
Jadad=4/4 
 
Strengths: assessors 
blind, good 
description of 
randomisation 
process, ITT analysis, 
description of drop-
outs  
 
Weaknesses: 
different retention 
rates across study 
sites, low compliance 
to treatment rates, no 
follow-up 
CG: GHQ-28, QCPR, 
HADS, RSS, EQ-5D, 
CSRI 
 
Baseline, 3 and 10 
months 
CG:  
 No sig. difference between the two groups in overall 
psychological distress (GHQ-28), stress (RSS), anxiety and 
depression (HADS), quality of the PWD-CG relationship 
(QCPR), quality of life (EQ-5D) at any time point. 
 Sig. higher anxiety in the intervention group compared to 
control group at 10 months as assessed by the anxiety 
subscale of the GHQ-28 
CG-=Caregiver, PwD= Person with Dementia 
AMI(E)= Autobiographical Memory Interview (extended), BI= Barthel Index, CAS= Client Assessment summary, CB= Caregiver Burden, CSD= Cornell Scale for 
Depression, CSQ= Client Satisfaction Questionnaire, CSRI=Client Services Receipt Inventory, EQ-5D=European Quality of Life- 5 Dimensions, GAI= Geriatric Anxiety 
Inventory, GDS= Geriatric depression Scale, GES= Group Evaluation Scale, GHQ= General Health Questionnaire, HADS=Hospital Anxiety and Depression Scale,  
MMSE= Mini Mental State Examination, N-EMD=Neuropsychiatric Inventory-Emotional Distress Scale, NPI= Neuropsychiatric Inventory, PSWQA= Penn State Worry 
Questionnaire, QCPR=Quality of Carer-Patient relationship, QoL-AD= Quality of Life in Alzheimer’s Disease Evaluation Scale, RAID= Rating Anxiety in Dementia Scale, 
RMBPC= Revised Memory and Behavioural Problems Checklist, RSS= Relative’s Stress Scale, SAS= Staff Assessment summary  
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Psychosocial interventions 
 
Authors Design, intervention, 
duration of intervention 
& level of 
individualisation 
N Intervention received Outcome measures 
and assessment 
points 
Results Quality Rating 
Dias et al. 
(2008) 
RCT 
 
Home Care Programme  
vs. waiting list control 
 
Home based, flexible 
stepped-care Programme 
 
Duration: 6 months 
 
Fully individualised  
81 dyads 
 
PWD: referrals for behaviour 
management as appropriate  
PWD: EASI, NPI 
(severity) 
PWD:  
 Non-sig. reduction in behavioural disturbances (NPI) and 
functional ability (EASI).  
Jadad: 4/4 
 
Strengths: attempted 
to use blind assessors 
(although success of 
blinding was limited), 
drop outs adequately 
dealt with  
 
Weaknesses: no 
follow-up, small N 
therefore inadequate 
power to detect 
significant changes in 
behaviour and 
functioning, attrition 
due to death high , 
otherwise low 
CG: support in activities of 
daily living 
 
Both: psycho-education re: 
dementia, behavioural problems 
and their management; family 
networking, signposting. 
CG: Zarit Burden 
Scale, NPI (burden), 
GHQ-12 
 
Baseline, 3 and 6 
months 
CG: 
 Sig. improvement in mental health (GHQ-12) and burden as 
measured by the NPI but not the Zarit Burden Scale 
Dröes et 
al. (2006) 
Quasi-experimental pre-
test post-test matched 
control group design  
 
Meeting Centre Support  
Programme vs. regular day 
centre care 
 
Duration: 7 months 
 
Partially individualised 
(fixed programme but 
some optional components) 
128 dyads 
 
PWD: Social club (inc. 
recreation/social activities, 
reality orientation, 
reminiscence, validation, 
psychomotor therapy, music 
therapy) 
PWD:  ASEP 
(inactivity and 
aggressive behaviour 
subscales), CDS, 
Behaviour 
Observation Scale 
(non-social behaviour 
subscale), 
Philadelphia Geriatric 
Centre morale Scale, 
NPI (severity), time to 
admission to nursing 
home 
PWD:  
 Sig. longer delay in time to admission to nursing home  
 Sig. less chance of being admitted for intervention group.   
 Near sig. increase in behavioural disturbances (NPI) in 
intervention group 
(effects on remaining outcomes not reported as reported in 
previous article) 
York= adequate 
 
Strengths: 
description of drop 
outs, successful group 
matching confirmed 
statistically, outcome 
measures delivered 
according to balanced 
incomplete block 
design to avoid 
systematic effects 
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CG: Informative meetings, long 
term discussion group 
 
Both: Consulting hour, social 
festivities, excursion, case 
management 
CG: GHQ-28, Sense 
of Competence Scale, 
Jalowiec Coping 
Scale, Social Support 
List, adapted Use of 
Services checklist, 
Loneliness Scale, NPI 
(burden), satisfaction 
with service 
questionnaire  
 
Baseline and 7 
months 
 
CG:  
 sig. greater reduction in psychological and psychosomatic 
symptoms (GHQ-28) following intervention for carers who 
felt lonely at start of programme 
 Sig. decrease in expressed feelings of burden between at  7 
months in intervention group  on a single ‘burden question’ 
on satisfaction questionnaire 
 No sig. difference between groups for sense of competence 
(Sense of Competence Scale), coping behaviour (Jaloweic 
Coping Scale), loneliness (Loneliness Scale), experienced 
social support (Social Support List), experienced support 
from services (Use of Services Checklist),  impact of 
behavioural disturbances (NPI)  
 
Weaknesses: control 
group data taken from 
previous study, 
assessors not blind, no 
adjustment of alpha 
level to account for 
multiple analyses, 
under powered, 
unbalanced group 
sample size (94 vs. 
34), no follow up, 
groups not randomly 
assigned 
Waldorff 
et al. 
(2012) 
RCT 
 
Routine follow-up plus 
psychosocial support 
programme vs. routine 
follow-up only (following 
dementia diagnosis 
 
Duration: 8-12 months 
 
Fully individualised  
330 dyads PWD: 5 week course inc. info 
on key issues of dementia and 
its consequences and handouts 
on different topics  
 
PWD: MMSE, CDS, 
EQ-VAS (PWD & 
CG rated), QoL-AD, 
NPI, ADSC-ADL 
PWD:  
 No sig. effect of treatment at either 6 or 12 months for all 
measures: cognition (MMSE), depression (CDS), health-
related quality of life (EQ-VAS), quality of life (QoL-AD), 
behavioural disturbances (NPI), functional ability (ADSC-
ADL) 
Jaded=4/4 
 
Strengths: assessors 
blind, ITT analysis, 
description of drop 
outs and analysis 
controlled for drop 
out, a priori power 
calculation 
 
Weaknesses: variable 
inclusion period, no 
follow-up 
CG: 5 week course inc. formal 
education re: dementia and 
handouts on different topics 
 
Both: Routine follow up plus 
counselling sessions, 
comprehensive written info., 
telephone support 
CG: GDS, EQ-VAS 
 
Baseline, 6 and 12 
months 
CG:  
 No sig. effect of treatment at either 6 or 12 months for all 
measures: depression (GDS), health related quality of life 
(EQ-VAS) 
CG-=Caregiver, PwD= Person with Dementia 
ADSC-ADL= Alzheimer’s Disease Cooperative Study Activities of Daily Life Scale, ASEP= Assessment Scale for Elderly Patients, CSD= Cornell Scale for Depression, 
EASI= Everyday Abilities Scale for India, EQ-VAS= European Quality of Life Visual Analogue Scale, GDS= Geriatric depression Scale, GHQ= General Health 
Questionnaire, IADL= Instrumental Activities of Daily Living, MMSE= Mini Mental State Examination, NPI= Neuropsychiatric Inventory, QoL-AD= Quality of Life in 
Alzheimer’s Disease Evaluation Scale. 
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Support Group Interventions 
 
Authors Design, intervention, 
duration of intervention 
& level of 
individualisation 
N Intervention received Outcome measures 
and assessment 
points 
Results Quality Rating 
Gaugler 
et al. 
(2011) 
Single group, pre-test, 
post-test design 
 
Memory Club 
 
Duration: 10-13 weeks 
 
Fixed programme 
PWD: 63 Both: weekly 90 minute 
sessions involving a) joint 
support groups, b) separate 
group sessions for PWDs and 
CGs, c) joint wrapping up 
session. Weekly sessions cover 
different topics including: 
information about dementia, 
communication, relationships, 
confidence, future planning, 
increasing support. 
PWD: Ratings of 
effectiveness in 
completing activities, 
GDS, satisfaction 
survey, IADL 
dependence 
PWD:  
 Sig. increase in IADL dependency 
 No sig. change in depression (GDS) or ratings of 
effectiveness but high pre-test MMSE score sig. positively 
correlated with increased activity effectiveness 
 Moderate levels of satisfaction with service 
 
York= Poor 
 
Strengths: 
Intervention delivered 
across multiple sites, 
peer supervision to 
ensure consistency of 
objectives across sites 
 
Weaknesses: lacks 
internal validity due 
to lack of control 
group, assessments 
conducted by 
intervention 
facilitators, non-
standardised conduct 
of intervention across 
the 3 research sites, 
no follow-up 
 
 
CG: 61 CG: Care Partner 
Stress measure, Care 
Partner Effectiveness 
measure, GDS, 
Preparation Checklist, 
Anticipation of Care 
(3 subscales), 
satisfaction with 
service questionnaire  
 
Baseline and 10-13 
weeks 
CG:  
 Sig. increase in perceived effectiveness, number of 
preparation activities undertaken & reports of preparation for 
care needs. 
 No sig. change in depression (GDS) or stress (care partner 
stress measure) 
 High levels of satisfaction with service 
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Logsdon 
et al. 
(2010) 
CRCT 
 
Early-stage memory loss 
vs. wait list control 
 
Duration: 9 weeks 
 
Manualised intervention 
142 dyads Both: weekly manual-based 
structured support programme. 
Sessions include PWD & CG 
who meet together for part of 
the session and separately for 
the rest. 
PWD: QoL-AD, SF-
36, GDS, RMBPC 
 
 
 
PWD: 
 Sig. effect of group and time on quality of life (QoL-AD) 
and depression (GDS) favouring the intervention group.  
 No sig. difference in health-related quality of life (SF-36) or 
memory-related behaviour problems (RMBPC) 
Jadad=2/4 
 
Strengths: low 
attrition rate (although 
no description of drop 
outs), ITT analysis, 
adjustment of alpha 
level, analyses 
adjusted for clustering 
effects 
 
Weaknesses: group 
allocation done on 2:1 
ratio, unclear if 
assessors were blind, 
no follow-up, no 
report of sample size 
calculation 
CG: GDS, FAM 
(communication, 
affective expression 
& involvement 
subscales), PSS, Self-
Efficacy Scale 
 
Baseline and post-
treatment 
CG:  
 No sig. differences in depression (GDS), communication 
(FAM), stress (PSS), self-efficacy (Self-Efficacy Scale) 
CG-=Caregiver, PwD= Person with Dementia 
FAM= Family Assessment Measure, GDS= Geriatric depression Scale, PSS= Perceived Stress Scale, QoL-AD= Quality of Life in Alzheimer’s Disease Evaluation Scale, 
RMBPC= Revised Memory and Behavioural Problems Checklist, SF-36= Short Form Health Survey. 
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Rehabilitation Interventions 
Authors Design, intervention,  
duration of intervention 
& level of 
individualisation 
N Intervention received Outcome measures 
and assessment 
points 
Results Quality Rating 
Gitlin et 
al. (2008) 
RCT  
 
Tailored Activity 
Programme vs. wait list 
control 
 
Duration: 4 months 
 
Fully individualised  
60 dyads PWD: no individual 
intervention (see both) 
PWD: Agitated 
Behaviours in 
Dementia Scale,  
RMBCP, CSD, 5 item 
activity engagement 
measure, QoL-AD 
PWD:  
 Sig. main effect of treatment for frequency of behavioural 
occurrences (shadowing and repetitive questioning), agitated 
and augmentative behaviours, activity engagement and 
ability to keep busy, with intervention group doing sig. better 
on each. 
 Trend towards improved quality of life (QoL-AD) 
 no sig. impact on depression (CSD) 
Jadad=4/4 
 
Strengths: assessors 
blind, appropriate 
randomisation, low 
attrition, high average 
session participation 
 
Weaknesses: no 
follow-up, no 
adjustment of alpha 
level, pilot study with 
no a priori sample 
size calculation 
CG: stress reducing techniques 
 
Both: OT led individualised 
activity prescription and 
planning 
CG: 5-item mastery 
scale, subjective 
burden rating scale, 
Zarit Burden Scale, 
objective burden 
measure, CES-D, 5-
item measure of 
confidence using 
activities, Task 
Management Strategy 
Index 
 
Baseline and 4 
months 
 
 
 
 
 
 
 
CG:  
 Sig. fewer hours spent ‘on duty’ and doing things for PWD 
in intervention group compared to controls. 
 Sig. greater mastery (mastery scale), self-efficacy using tasks 
(confidence using activities) and use of simplification 
techniques (task management strategy index) in intervention 
group at 4 months compared to controls. 
 No sig. impact of intervention on burden on any measure 
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Graff et 
al. (2006) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Graff et 
al. (2007) 
RCT 
 
Community OT  vs. care as 
usual 
 
Duration: 5 weeks 
 
Fully individualised  
135 Dyads PWD: no individual 
intervention (see both) 
 
 
PWD: Assessment of 
Motor and Process 
Skills (process scale), 
Interview of 
Deterioration in Daily 
Activities in 
Dementia 
(performance scale)  
PWD:  
 Sig. improvement in daily functioning (Assessment of Motor 
and Process Skills, Interview of Deterioration in Daily 
Activities in Dementia) across time and group 
Jadad= 4/4 
 
Strengths: assessors 
blind, appropriate 
randomisation, low 
attrition rate, ITT 
analysis, adjustment 
of alpha level, follow-
up 
 
Weaknesses: 
recruitment limited to 
one institution 
therefore results may 
not generalise 
CG: cognitive and behavioural 
interventions to support use of 
effective supervision, problem 
solving and coping strategies 
 
Both: home-based twice 
weekly sessions– goal setting, 
development of meaningful 
activities, home adaptations, 
ADL training 
CG: Sense of 
Competence 
questionnaire 
Baseline, 6 and 12 
weeks 
CG:  
 Sig. increase in competence (Sense of Competence 
questionnaire) across time and group  
 
PWD: no individual 
intervention (see both) 
 
 
PWD: Dqol, GHQ-
12, CSD 
 
PWD:  
 Sig. greater increase in quality of life (Dqol), health status 
(GHQ) and mood (CSD) in intervention group at 6 and 12 
weeks 
CG: cognitive and behavioural 
interventions to support use of 
effective supervision, problem 
solving and coping strategies 
 
Both: Occupational Therapy – 
development of meaningful 
activities, home adaptations, 
ADL training 
 
 
 
 
 
 
CG: Dqol, CES-D, 
GHQ-12, Mastery 
Scale 
 
Baseline, 6 and 12 
weeks 
CG:  
 Sig. greater improvement in health status (GHQ), mood 
(CES-D) and sense of control (Mastery scale) in intervention 
group at 6 and 12 weeks 
 Sig. better quality of life (Dqol) at 6 weeks on 2 out of 4 
subscales (aesthetics and self-esteem) and on all subscales at 
12 weeks 
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Kurz et 
al. (2012) 
RCT 
 
Cognitive Rehab and 
Psychotherapy vs. standard 
medical management 
 
Duration: 12 weeks 
 
Manualised intervention 
201 dyads PWD: cognitive rehabilitation 
and CBT programme delivered 
in 4 modules – introduction, 
neuro-rehabilitation (use of 
external memory aids, 
introduction of daily routines), 
psychotherapy strategies (day 
structuring, activity planning, 
reminiscence), closing module 
PWD: B-ADL, AFIB, 
DEMQOL, GDS, 
NPI, WMS-R, Trail 
Making test, 
Regensburg Word 
Fluency test,  
 
Satisfaction  
Questionnaire ZUF-8 
PWD:  
 No sig. impact of intervention on activities of daily living (B-
ADL, AFIB), quality of life (DEMQOL), behaviour 
disturbance (NPI), cognitive ability (WMS-R, Trail Making 
Test, Word Fluency test) at 3 and 9 months 
 Sig decrease in depression (GDS) for females but not males 
at 3 and 9 months in intervention group compared to control 
group 
 No sig. difference between groups in treatment satisfaction 
Jadad=4/4 
 
Strengths: assessors 
blind, ITT analysis, 
treatment 
standardised, control 
of treatment fidelity, 
low attrition, good 
participant adherence 
to treatment, follow-
up 
 
Weaknesses: low 
sensitivity of B-ADL 
and AFIB, short 
duration of treatment 
CG: Attendance at half PWD 
sessions, written information on 
all modules 
CG: BDI, Zarit 
Burden Interview, 
Satisfaction 
Questionnaire-ZUF-8 
 
Baseline, 3 and 9 
months 
CG:  
 Sig. increase in burden (Zarit Burden Interview) in 
intervention group but not control group at three months but 
no effect of group at 9 months 
 No sig. difference between groups in changes to depression 
or treatment satisfaction 
Viola et 
al. (2011) 
Single blind, non-
randomised controlled trial 
 
Multidisciplinary 
Cognitive rehabilitation vs. 
wait list control 
 
Duration: 12 weeks 
 
Fixed programme 
41 dyads PWD: multidisciplinary 
cognitive rehabilitation 
including cognitive 
rehabilitation and training, 
speech, art, physio and 
occupational therapy, cognitive 
stimulation and physical 
training 
PWD: MMSE, SKT, 
NPI, GDS, QoL-AD 
PWD:  
 No change in cognition (MMSE, SKT) in intervention group, 
sig. decline shown in cognition on SKT but not MMSE in 
control group. 
 Sig. reduction in depression (GDS) and sig. improvement in 
quality of life (QoL-AD) in intervention but not control 
group.  
 No change in behavioural disturbances (NPI) for either group 
York= Adequate 
 
Strengths: assessors 
blind, good 
description of 
intervention,  groups 
well matched, 
standardised 
treatment 
 
Weaknesses: 
participants not 
randomised, small 
sample size, no 
follow-up 
CG: psychoeducation and 
psychological counselling 
CG: GDS, QoL-AD 
(carer protocol), NPI-
distress 
 
Baseline and 12 
weeks 
CG:  
 Sig. reduction in depression (GDS) and distress (NPI) and 
sig. improvement in quality of life (QoL-AD) in intervention 
but not control group. 
CG-=Caregiver, PwD= Person with Dementia 
AFIB=Aachen Functional Item Inventory, B-ADL= Bayer Activities of Daily Living, BDI= Beck Depression Inventory, CES-D= Centre of Epidemiological Studies 
Depression Scale, CSD= Cornell Scale for Depression, DEMQOL=Quality of Life in dementia,  Dqol= Dementia Quality of Life Instrument, GDS= Geriatric depression 
Scale, GHQ= General Health Questionnaire, MMSE= Mini Mental State Examination, NPI= Neuropsychiatric Inventory, QoL-AD= Quality of Life in Alzheimer’s Disease 
Evaluation Scale, RMBPC= Revised Memory and Behavioural Problems Checklist, SKT= Short Cognitive Test, WMS-R= Wechsler Memory Scale-Revised. 
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Case Management Interventions 
 
Authors Design, intervention, 
duration of intervention 
& level of 
individualisation 
N Intervention received Outcome measures 
and assessment 
points 
Results Quality Rating 
Callahan 
et a. 
(2006) 
CRCT 
 
Care Management  vs. 
usual care 
 
Duration: 12 months 
 
Partially individualised 
(some standardised  and 
some individualised 
elements) 
153 dyads 
 
PWD: Support group PWD: NPI (severity), 
Activities of Daily 
Living, Health Care 
Resource Use, CSD, 
Telephone Interview 
for Cognitive Status 
(telephone version of 
MMSE), rate of 
nursing home 
placement 
PWD:  
 Sig. greater improvement in behavioural disturbances (NPI) 
at 12 and 18 months  in intervention group compared to 
control 
 No sig. impact of intervention on depression (CSD), 
cognition (MMSE), activities of daily living or rates of 
nursing home placement.  
 Sig. increase in health care use by intervention group 
compared to controls at 12 and 18 months 
Jadad=4/4 
 
Strengths: 
assessors blind, low 
chance of Type I error 
on primary outcome 
measures, ITT 
analysis, good 
handling of drop outs, 
follow-up, sites 
randomised before 
recruitment but  
recruitment team 
blind to 
randomisation 
clusters, analyses 
adjusted for clustering 
effects  
 
Weaknesses: 
underpowered to 
detect changes on 
secondary measures, 
baseline differences in 
two groups, PwD in 
intervention group 
more likely to be 
taking medication, 
control participants 
received a substantial 
intervention 
CG: Support Group, coping 
skills, caregiver guide form 
Alzheimer’s Association 
 
Both: Care manager, education 
on communication skills, legal 
and financial advice, 
behavioural interventions 
(based on individual need) 
CG: NPI (burden), 
PHQ-9, satisfaction 
with PWD’s care 
(assessed with single 
question) 
 
Baseline, 6, 12 and 18 
months  
CG:  
 Sig. improvement in distress (NPI) at 12 months but not 18 
months  
 Sig. improvement in mood at 18 months. 
 Sig. greater number of CGs report being satisfied with PWD 
care at 12 months but no difference at 18 months 
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Jansen et 
al. (2011) 
RCT 
 
Nurse-led case 
management vs. care as 
usual 
 
Duration: 12 months 
 
Partially individualised 
(some standardised  and 
some individualised 
elements) 
99 dyads PWD: development of 
individualised care plan,  on-
going monitoring as required,  
PWD: Dqol, health 
care utilisation 
PWD:  
 No sig. impact of intervention on quality of life (Dqol) or 
health care utilisation 
Jadad=4/4 
 
Strengths: assessors 
blind, a priori sample 
size calculation, 
suitable N, drop out 
adequately addressed, 
ITT analysis, low 
attrition 
 
Weaknesses: 
included participants 
with no formal 
diagnosis of 
dementia, insufficient 
power to detect small 
effects, no follow-up, 
poor treatment fidelity 
CG: formulation of 
individualised care plan 
 
Both: Assessment, sign posting, 
information and advice, 
referrals to relevant services,  
family meetings for other 
relatives to increase social 
support and provide 
psychoeducation 
CG: SCQ, 
consequences of 
caring, satisfaction 
with own 
performance, 
satisfaction with 
PWD, SF-36, CES-D, 
SPPIC, health care 
utilisation 
 
Baseline, 6 and 12 
months 
CG:  
 No sig. impact of intervention on sense of competence 
(SCQ), quality of life (SF-36), depression (CES-D), burden 
(SPPIC) 
 Sig. decline over time for both groups in satisfaction with 
PWD and consequences of caring (SCQ).  
 No effect of time on other measures 
Specht et 
al. (2009) 
CRCT 
 
Nurse Care Manager vs. 
traditional case 
management 
 
Duration: not stated 
 
Fully individualised  
PWD: 
249 
PWD: no individual 
intervention (see both) 
PWD: MMSE, 
Global Deterioration 
Scale, Activities of 
Daily Living index, 
Functional 
Assessment II, 
Behaviour Rating 
Checklist (13 items) 
PWD:  
 Sig. increase in functional ability (ADL index) in 
intervention group across all time points (no change in 
control group).  
 No sig. difference between the two groups in functional 
ability in either follow-up period 
 No sig. effect of time or group on cognition (MMSE) , stage 
of dementia (Global Deterioration Scale), behaviours 
(Behaviour Rating Checklist) 
Jadad= 1/4 
 
Strengths: alpha level 
adjusted for some 
analyses, differences 
between completers & 
drop outs explored 
 
Weaknesses: sites 
randomised before 
recruitment, 
recruitment team not 
blind, assessors not 
blind, data collection 
points variable, no 
ITT analysis, attrition 
high, inclusion of 
PWDs without formal 
dementia diagnosis,  
no sample size 
calculation reported,  
CG: 168 CG: optional CG support group 
 
Both: Nurse care manager, 
including delivery of direct 
services using traditional and 
non-traditional methods, as well 
as traditional case management 
CG: NOC (measuring 
wellbeing, endurance 
and stressors). 
 
Baseline, 3-9monts, 9-
15 months 
CG:  
 No sig. increase in stress (NOC) in intervention group, 
increase in control group at 3-9months but not 9-12 months. 
At 3-9months control group sig, more likely to have 
extensive stress than intervention group 
 No change in wellbeing (NOC) for intervention group, sig. 
decrease in wellbeing in control group at both follow-up 
periods. Control group sig. more likely to have extremely 
compromised wellbeing at 9-15 months. 
 Sig. increase in endurance potential (NOC) at 3-9 months in 
intervention group only  
33 
 
Vickery 
et al. 
(2006) 
CRCT 
 
Care management vs. care 
as usual 
 
Duration: 12 months 
 
Fully individualised 
408 dyads Both: guideline-based 
individualised care 
management, including 
assessment, individualised 
treatment plan, referral to 
appropriate services, education 
and support. 
PWD: HUI-3, health 
state classification, 
overall health care 
quality (care-rated) 
PWD:  
 Sig. smaller decline in health related quality of life (HUI-3) 
at 18 months in intervention group, 
 Sig. better health care quality (carer rated) at 12 and 18 
months for intervention group 
Jadad= 3/4 
 
Strengths: ITT 
analysis, power 
analysis and data 
analysis adjusted to 
account for clustering 
effects, follow-up 
 
Weaknesses: no 
between group 
comparison of drop 
outs 
CG: Carer Survey 
(knowledge of 
dementia, confidence 
& mastery, health 
related QoL, social 
support, unmet need 
for assistance 
managing problem 
behaviours) 
 
Baseline, 12 and 18 
months 
CG:  
 No sig. main effect of time or group on knowledge or use of 
services. 
 Intervention group sig. higher confidence and mastery, social 
support and sig. fewer unmet needs (carer survey) at 18 
months than control group.  
 No between group difference in health-related Qol at 18 
months 
 
Both:  
 Sig. more dyads received community services, respite care, 
health services and professional caregiving services in 
intervention group.  
 At follow-up sig. more dyads enrolled on Alzheimer’s 
Association programme for wandering in intervention group. 
 
CG-=Caregiver, PwD= Person with Dementia 
CES-D= Centre of Epidemiological Studies Depression Scale, CSD= Cornell Scale for Depression, Dqol= Dementia Quality of Life Instrument, HUI-3= Health Utilities 
Index-3, MMSE= Mini Mental State Examination, NPI= Neuropsychiatric Inventory, NOC= Nursing Outcomes Classification, PHQ-9= Patient Health Questionnaire-9, 
SCQ= Sense of Competence Questionnaire, SF-36= Short Form Health Survey, SPPIC= Self-Perceived Pressure by Informal Care 
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Study Characteristics 
 Of the 18 studies included in the review, 13 were RCTs. Of these four were 
CRCTs, although none of these studies identified themselves as such in the title or 
abstract. The remaining five studies were non-randomised trials and of these two 
used a quasi-experimental design and three used a single group design.  
 All but three studies specified that research participants had a formal 
diagnosis of dementia. Ten studies used formal diagnostic criteria such as the 
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (4th ed.; 
DSM–IV; American Psychiatric Association, 1994) to confirm diagnoses and three 
studies stated that diagnosis was confirmed through screening medical records. Two 
studies by Dröes, Meiland, Schmitz and Tilburg (2006) and Vickery et al., (2006) 
specified that participants had a diagnosis of dementia but did not state how this was 
made or confirmed. Bakker et al. (2011) included people with a DSM-IV diagnosis 
of dementia or an amnesic disorder or other cognitive impairment, Specht, Bossen, 
Hall, Zimmerman and Russell (2009) included participants with memory 
impairments and Jansen et al. (2011) required participants to have an MMSE score of 
below 24 and a risk of dementia of 50% or more according to the 7 Minute Screen 
(7MS). 
Description and Evaluation of Interventions 
Psychotherapeutic Interventions 
Description: Psychotherapeutic interventions offer theory-based 
psychological therapies. Four studies investigated the impact of psychotherapeutic 
interventions. Bakker et al. (2011) evaluated a nursing- home based integrative 
psychotherapeutic programme and although the intervention was delivered in a 
nursing home setting all participants were community dwelling. Meanwhile, Woods 
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et al. (2012) examined the effectiveness of joint reminiscence groups, which were 
manual based and covered a number of themes including childhood, schooldays, 
working life, marriage, and holidays. Two further studies utilised single group time 
series designs.  Paukert et al. (2010) investigated the effectiveness of a home-based, 
manualised cognitive-behavioural therapy (CBT) progamme for anxiety, whilst 
Weber et al. (2009) evaluated a psychotherapeutically oriented day hospital 
programme. 
 Effectiveness: Bakker et al. (2011) reported that their nursing home 
programme resulted in significant reductions in the neuropsychiatric symptoms of 
people with memory impairments (as rated by carers but not staff) and in carer 
burden, as well as significant increases in carer competence, when compared to usual 
care. Initial improvements in the cognition of people with memory impairments were 
not maintained at 6 month follow-up and self-care was significantly poorer in the 
intervention group. The generalisability of the results is limited because only 50% of 
eligible dyads consented to participate. Furthermore, only 65% of participants had a 
DSM-IV diagnosis of dementia. The RCT by Woods et al. (2012) revealed no 
significant effect for people with dementia following participation in reminiscence 
groups except an increase in use of day care services. For carers, anxiety was 
observed to increase on one measure but not another and no other significant effects 
were observed. This study was rated as good quality and adhered to all criteria on the 
Jadad Scale. In contrast, the study by Paukert et al. (2010) was rated as poor quality. 
Improvements for in people with dementia following CBT for anxiety were 
demonstrated across all measures of anxiety and on a measure of depression and 
carers displayed reductions in distress. However, results across different measures of 
anxiety were not consistent between or within participants, the sample size was only 
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nine meaning results could not be generalised and the study did not have power to 
detect any statistically significant effects. The study by Weber et al. (2009) was also 
rated as poor quality. A significant decrease in behavioural disturbance for people 
with dementia was observed. However, although staff reports of progress indicated a 
significant positive effect of treatment, self-ratings of progress did not improve 
indicating that people with dementia did not experience any change themselves. This 
was the only study found which collected but did not report carer outcomes.  
Psychosocial Interventions 
Description: Psychosocial interventions focus on the interaction between 
psychological and social or environmental factors .Three studies investigating 
psychosocial interventions were found in the review. Using an RCT, Waldorff et al. 
(2012) compared routine follow-up plus a semi-tailored psychosocial intervention 
(Danish Alzheimer Study Intervention, DAISY) with routine follow-up only for 
newly diagnosed people with dementia and their carers. In a second RCT, Dias et al. 
(2008) investigated the effectiveness of a home-based, flexible stepped-care outreach 
intervention for people with dementia and their carers living in Goa. A third 
psychosocial intervention was evaluated by Dröes et al. (2006), who employed a 
quasi-experimental two group design to explore the impact of the Meeting Centre 
Support Programme (MCSP).  
Effectiveness: Waldorff et al. (2012) found no significant effects for either 
people with dementia or carers. This study was rated as high quality and despite the 
lack of any significant findings the authors recommend further research as this was 
an exploratory study. The study may have been under powered because sample size 
calculations did not adjust for multiple primary outcomes and assessment time points. 
Dias et al. (2008) observed a significant reduction in carer distress and general 
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mental health. No significant effects for people with dementia were observed. The 
quality of this trial was high although it may also have been underpowered to detect 
smaller changes. The final psychosocial intervention evaluated by Dröes et al (2006) 
resulted in significantly longer delay in time to admission to nursing home for people 
with dementia. However, no significant treatment effect was found for carers on any 
of the primary outcome measures. Secondary analysis revealed a significant 
reduction in psychological and psychosomatic symptoms only for carers who were 
rated as lonely at baseline. A significant reduction in burden was observed but this 
was based on a single item on a carer satisfaction questionnaire. Caution is needed 
when interpreting these results as no adjustment was made to the alpha level to 
account for multiple analyses therefore increasing the chance of finding significant 
group differences. At the same time the study was under powered meaning that 
significant effects may have gone undetected.  
Support Group Interventions 
Description: Two support group programmes offering a combination of 
psychoeducation and peer support for people with early stage dementia and their 
carers were identified. Logsdon et al. (2010) randomised dyads at a ratio of 2:1 to 
either the Early Stage Memory Loss (ESML) intervention or a wait list control group. 
Gaugler et al. (2011) evaluated the effect for dyads of participating in a joint 
Memory Club support group programme whose aim was to increase knowledge, 
improve communication and confidence, enhance feelings of support, reduce 
isolation, increase self-efficacy and improve awareness of wider support services.   
Effectiveness: The results of these two studies were mixed. Logsdon et al. 
(2010) demonstrated that their intervention resulted in significant improvements in 
the quality of life and significant reductions in depression of people with dementia in 
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comparison to the control group, but found no effect on health-related quality of life 
or memory-related behaviour problems. No benefits for carers were found. The 
quality of this study was average and benefited from low attrition rates. However, it 
is unclear whether assessors were blind and whether a priori sample size calculations 
had been conducted. Gaugler et al. (2011) reported a significant increase in the 
functional dependency of people with dementia and no effect on their mood or 
perceived effectiveness. However, the intervention did significantly improve carers’ 
preparedness for the future and perceived effectiveness, although had no effect on 
their mood or stress. This study was rated as poor quality and as the intervention was 
not standardised across research sites it is difficult to draw conclusions about the 
source of the positive outcomes observed.  
Rehabilitation-Focused Interventions 
Description: Rehabilitation interventions aim to optimise the capabilities of 
people with dementia. Two forms of rehabilitation interventions were found, those 
that focused on cognitive rehabilitation and those that focused on functional 
rehabilitation, the latter of which centred predominantly on activities of daily living. 
Two studies investigating cognitive rehabilitation interventions were found. Kurz et 
al. (2012) investigated the impact of cognitive rehabilitation combined with 
cognitive-behavioural treatment. This study has been included in this section as it 
focuses more strongly on rehabilitation than psychotherapy. Viola et al. (2011) 
investigated the effectiveness of a multidisciplinary cognitive rehabilitation 
programme.  Some participants originally in the control condition subsequently went 
on to complete the intervention condition.  
Two RCTs exploring interventions designed to improve functional ability 
were found, one of which was described in two papers (Graff et al., 2006, 2007). 
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These authors examined the effects of a community occupational therapy programme 
aiming to support people with dementia to improve their functional abilities by 
maximising existing compensatory and environmental strategies. Gitlin et al. (2008) 
investigated the impact of an occupational therapist led Tailored Activity Program 
(TAP). This programme aimed to reduce the vulnerability of people with dementia to 
their environment and increase their threshold for tolerating stress by devising 
individualised activity programmes designed to enhance preserved abilities.  
Effectiveness: Kurz et al. (2012) found no change in the functional ability, 
quality of life, behavioural disturbance or cognition of people with dementia. A 
significant decrease in depression was observed in females but not males. Although 
carer burden had increased at the end of treatment this effect disappeared at follow-
up. This trial was high quality but it should be noted that psychological interventions 
were included alongside cognitive rehabilitation strategies meaning results are 
representative of a joint intervention. The intervention evaluated by Viola et al. 
(2011) resulted in a significant reduction in depression and a significant increase in 
quality of life for both people with dementia and carers, as well as significant 
reductions in carer distress. No change in the cognition or behaviour of people with 
dementia was observed in the intervention group, whereas a small but significant 
decrease in cognition was observed in the control group. This study included well 
matched treatment groups and was rated as adequate.  
Gitlin et al. (2008) demonstrated that their intervention resulted in a reduction 
in behavioural disturbance and an increase in engagement and ability to keep busy 
for people with dementia. For carers a significant increase in competence was 
observed, alongside a reduction in time spent caring. Similarly positive results were 
reported by Graff et al. (2006, 2007) whose intervention significantly improved the 
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functional ability, quality of life, health status and mood of people with dementia and 
the competence, health status, mood and sense of control of carers. Both studies 
investigating functional rehabilitation were rated as high quality, although the 
generalisability of Graff et al.’s (2006, 2007) results may be limited as recruitment 
was confined to one institution. 
Case Management Interventions 
Description: Case management interventions focus on the co-ordination of 
services and the rehabilitation, support  and care of participants by utilising a range 
of strategies, including psychoeducation, sign-posting, skills training, behavioural 
management and care co-ordination, based on individual assessments of need. Four 
studies investigated the impact of case management. Callahan et al. (2006) developed 
an individualised collaborative care management programme to supplement usual 
treatment. A similar programme was evaluated by Vickery et al. (2006) who 
compared a multi-component, guideline based care management programme with 
care as usual. Care managers used algorithm software to develop and initiate 
individualised treatment action plans based on assessment information. Specht et al. 
(2009) described the effectiveness of enhanced case management delivered by 
dementia nurse care managers. Finally, Jansen et al. (2011) explored a more 
traditional case management programme whereby the case managers’ role was 
predominantly one of individualised co-ordination.  
Effectiveness: Jansen et al. (2011) found no benefits of case management for 
either people with memory impairments or their carers. Although this study was high 
quality it included people with dementia symptoms but not a formal diagnosis and 
the authors concluded that this intervention may not be effective if offered too early. 
Other studies did find benefits of case management. Callahan et al. (2006) observed 
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significant improvements in the behavioural and psychological symptoms of people 
with dementia and an increase in their health care use, as well as significant 
improvements in carer mood. Other improvements were observed but not maintained 
at follow-up. This study may have been underpowered to detect changes on 
secondary outcome measures and the impact of the intervention may have been 
underestimated because the control group received substantial input. Meanwhile, 
Vickery et al. (2006) reported a significantly smaller decline in the health related 
quality of life of people with dementia compared to usual care. The intervention had 
no effect on carer knowledge or health related quality of life but did result in 
significantly improved carer confidence, mastery, social support and fewer unmet 
needs. A fourth study (Specht et al., 2009) was of poorer quality. No significant 
changes for people with memory impairments were observed. However, carer stress 
and wellbeing was maintained in the intervention group but declined in the control 
group and endurance potential was greater in the intervention group. This study not 
only included people without a formal diagnosis of dementia, it also included people 
with no carer, although analyses controlled for this.   
Discussion 
Summary of the Effectiveness of Interventions 
This review of the literature revealed that combined interventions for people 
with dementia and their carers are not consistently effective. The mixed outcomes 
reported and variability in the quality of the studies means that definitive conclusions 
are difficult to draw. This is in line with the conclusions reached in the previous 
review by Smits et al. (2007). The effectiveness of psychotherapeutic interventions 
appears to be limited. Reminiscence therapy was largely ineffective, a therapeutic 
day hospital programme displayed very limited effectiveness and conclusions as to 
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the effectiveness of CBT for anxiety are limited by the poor quality nature of the 
study. A psychotherapeutic nursing-home based programme was more promising, 
although only resulted in consistent benefits for carers.  No consistent positive 
outcomes from psychosocial interventions were reported across the three studies 
included in the review. Support group programmes appear to facilitate positive 
outcomes for people with dementia, although conclusions as to the effectiveness of 
such interventions for carers are mixed. Furthermore, both the studies described were 
of poor quality meaning that it is not possible to be confident in the results observed. 
Cognitive rehabilitation programmes appear to have no impact on the cognitive 
abilities of people with dementia. In contrast, functional rehabilitation interventions 
appear to be effective for both people with dementia and carers. Finally, case 
management appears to be an effective intervention for both people with dementia 
and carers if offered to those with a formal diagnosis of dementia.  
Methodological Limitations  
There were a number of common methodological issues identified in the 
included studies. Firstly, over half did not include a follow-up assessment, thus 
conclusions as to their long-term effectiveness cannot be drawn. Secondly, in one 
third of the studies assessments were completed by assessors not blind to 
participants’ group allocation, introducing the possibility of bias (Schulz & Grimes, 
2002). Furthermore, the generalisability of some studies was limited, for example 
because they only included participants from single institutions, thus limiting the 
extent to which results can be applied beyond the sample studied. Another weakness 
of several studies was a lack of power. Without an adequate sample size studies risk 
making type II errors, that is, reporting false negative results through being unable to 
detect significant effects where they exist. Additional limitations included high levels 
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of attrition, lack of description of drop-outs and failure to adjust alpha-levels to 
account for multiple analyses.  
Effectiveness of Interventions for People with Dementia by Outcome 
 Outcomes for people with dementia were classified as following: behavioural 
problems; cognitive functioning, mental health, functional ability, admission to an 
institution and quality of life. It appears that combined interventions programmes do 
not have a consistent effect on behavioural problems, or quality of life although do 
not result in any decline in either outcome. Interventions are more likely to report no 
change in depression than to report an improvement and no evidence was found of an 
improvement in anxiety following any of the interventions.  Similarly no 
improvements in cognition were observed, including in the two studies designed 
specifically to target cognition, suggesting that cognition is not a promising target for 
interventions. Functional ability improved in the two studies specifically targeting 
this outcome. However, although several other studies observed no change, declines 
in functioning were observed in three studies. This suggests that careful monitoring 
of functioning should be included in interventions which do not specifically target 
functional ability as decline is possible. An inadequate number of studies reported 
outcomes for admission to institutions.   
Apart from interventions targeting functional ability which consistently 
resulted in improvements, no other consistent patterns between category of 
intervention and outcome observed emerged. Not all outcomes were assessed in each 
study meaning broader conclusions are further limited. Finally, the level of 
individualisation of intervention programmes does not appear to be related 
consistently to any specific type of outcome. 
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Effectiveness of Interventions for Carers by Outcome 
Outcomes for carers were classified into four categories: burden, mental 
health, competence and quality of life. Combined interventions appear to have no 
negative consequences for carers. Competence appears to improve most consistently 
and presents a promising target for interventions, with the impact on burden being 
more mixed. Mental health is more likely to remain stable than improve, with general 
mental health the most promising target for interventions. Depression and stress 
appear almost exclusively resistant to change. Only five studies reported outcomes 
for quality of life making it difficult to draw conclusions, although as with all other 
outcomes no negative effects were observed.  
No consistent pattern emerged between category of intervention and 
outcomes observed and the level of individualisation of intervention programmes 
does not appear to be related consistently to any specific outcomes. Again, not all 
outcomes were assessed in each study meaning broader conclusions are further 
limited. 
Effectiveness for both People with Dementia and Carers 
All but one study, that of Weber et al. (2009), reported outcomes for both 
people with dementia and carers. Only two studies (Graff et al., 2006, 2007; Paukert 
et al., 2010) reported consistently positive outcomes for both, whilst six studies 
found partially positive outcomes for both (Bakker et al., 2011; Callahan et al., 2006; 
Gitlin et al., 2008; Vickery et al., 2006; Viola et al, 2011 & Woods et al., 2012). Six 
studies found positive results for either people with dementia or carers, but not both 
(Dias et al., 2008; Dröes et al., 2006; Gaugler et al., 2011; Kurz et al., 2012; Logsdon 
et al., 2010 & Specht et al., 2009). Jansen et al. (2011) and Waldorff et al. (2012) 
found no positive outcomes for either people with dementia or their carers. No 
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consistent link between type of intervention and presence or absence of positive 
outcomes for people with dementia and their carers was found. Similarly, no 
consistent link between the level of individualisation of interventions and presence of 
absence of positive outcomes was found. 
Implications for Practice 
The lack of consistent positive results within each category of interventions 
and the small number of studies in each group makes any wider recommendations for 
practice as to the most effective combined interventions for people with dementia 
and their carers limited. However, case management appears to be an effective 
combined intervention when delivered to people with a formal diagnosis of dementia 
and may therefore represent a promising mode of intervention in practice. Similarly, 
although this review found only two studies offering functional rehabilitation 
interventions, both resulted in positive outcomes for people with dementia and their 
carers, providing initial, albeit limited, evidence to recommend the use of functional 
rehabilitation in practice. On the other hand, cognitive rehabilitation interventions 
appear not to impact the cognition of people with dementia making their use as a 
means of enhancing cognition in practice questionable. However, given the 
secondary benefits demonstrated they should not be abandoned, although realistic 
expectations of outcomes should be held in mind.  Whilst support group 
interventions appear to offer promising results, in particular for people with dementia, 
caution should be exercised before considering the use of such interventions in 
practice given the poor quality of both studies described. Combined 
psychotherapeutic interventions appear to result in limited outcomes and as such 
should be considered carefully before being implemented in practice and the mixed 
46 
 
outcomes from psychosocial interventions again warrants caution before use in 
practice.  
Implications for Research 
The limited number of studies in each category highlights the need for further 
research to allow more robust and definitive conclusions to be drawn. Larger scale 
studies are recommended to replicate those studies that were underpowered and 
future research should strive to ensure adequate power is achieved. The poor quality 
of some studies renders their conclusions less reliable and the limitations of these 
studies should be addressed in future research so as to provide more meaningful 
results. Interventions which do not result in positive outcomes for both people with 
dementia and their carers should consider modifications to target both members of 
the dyad more effectively and research to determine the active elements of each 
intervention would facilitate the development of efficient programmes. Finally, 
research studies should strive to use a homogeneous range of outcome measures to 
allow outcomes across studies to be more readily compared. 
More specifically, given the heterogeneous nature of psychotherapeutic 
interventions direct comparisons between studies is less reliable. Replication of 
studies using similar interventions would allow for greater reliability of results. In 
order to strengthen the conclusions as to the effectiveness of case management 
interventions, those interventions which included people without a formal diagnosis 
of dementia should be replicated with people with a formal diagnosis.   
Conclusions 
There is evidence that combined interventions for people with dementia and 
their carers can be effective, although definitive conclusions as to the best types of 
interventions are limited. Functional rehabilitation offers consistently positive 
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outcomes but requires further research to make this conclusion more reliable and 
case management appears to offer promising outcomes when offered to people with a 
formal dementia diagnosis. More high quality research is needed across all types of 
interventions to allow for reliable recommendations to be made. No 
recommendations as to the level of individualisation of programmes can be made as 
outcomes of studies at each level were mixed. Furthermore, no one type of outcome 
emerged as a consistently promising target for interventions, with different 
interventions resulting in different outcomes. Nevertheless, use of some combined 
interventions in practice may have positive outcomes for both people with dementia 
and their carers if chosen carefully. Monitoring of outcome in practice is 
recommended in order to adapt interventions to ensure their effectiveness.  
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Part 2: Empirical Paper 
 
Effectiveness of Weekly Cognitive Stimulation Therapy (CST) for People with 
Dementia and the Additional Impact of Enhancing CST with a Carer Training 
Programme 
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Abstract 
Background: Cognitive Stimulation Therapy (CST) is a widely used, evidence based 
intervention for people with dementia. Although designed as a 14 session, twice 
weekly intervention, anecdotal evidence suggests that CST is routinely delivered 
once a week for 14 weeks. However, this method of delivery has yet to be evaluated. 
In addition, CST does not, at present, include any formal carer training. The aim of 
the current study was firstly to evaluate the effectiveness of once weekly CST and 
secondly to determine any additional impact when enhancing CST with a carer 
training programme. 
Design: A single blind, randomised control trial was used. 68 people with dementia 
and their carers were recruited through three community Memory Assessment 
Services. Dyads were randomised to one of three conditions: CST plus carer training, 
CST only or a wait list control. People with dementia were administered standardised 
measures of cognition, quality of life and relationship with carer at baseline and 
again after 15 weeks. 
Results: 21 dyads were randomised to CST plus carer training, 24 to CST only and 
23 to the control group. There were no baseline differences between people with 
dementia across the three groups. At follow-up there were no significant differences 
between people with dementia in the three groups on any of the outcome measures.   
Conclusions: Weekly CST with or without carer training may not be an effective 
form of delivery. However, there are several possible explanations for the outcomes 
observed and further research is needed to determine the reliability of the results. 
Services currently offering weekly CST should collect routine outcome data from 
participants to support its use and provide practice-based evidence. 
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Currently in the UK there are an estimated 800,000 people living with 
dementia (Dementia 2012). Five percent of the population aged over 65  have 
dementia, with this figure rising to 20 percent in those aged over 80 and to 30 percent 
in those aged over 90 (National Service Framework for Older People, NSF-OP, 
2007). As the population continues to age the number of people diagnosed with 
dementia is also set to increase. Indeed, estimated figures predict that by 2021 there 
will be over one million people in the UK with dementia (Dementia 2012). Dementia 
is a progressive mental health disorder characterised by pervasive impairment of 
mental function.  Symptoms include a gradual loss of memory and cognitive 
disturbances that cause significant impairment.  
Given the progressive and chronic nature of dementia and the large number 
of people currently (and predicted to be) diagnosed with the condition, the need for 
effective and accessible treatments is paramount. Pharmacological treatments are 
available but these are not appropriate for everyone and can result in intolerable side 
effects for some. Much attention has therefore been focused on the development of 
non-pharmacological interventions for the treatment of cognitive, behavioural and/or 
emotional symptoms. The literature review of Cove (2013) provides a description of 
non-pharmacological interventions for people with dementia. 
Cognitive Interventions in Dementia 
Cognitive symptoms frequently predominate in those suffering from 
dementia. These symptoms, highlighted in the Diagnostic and Statistical Manual of 
Mental Disorders, Fourth Edition (4th ed.; DSM–IV; American Psychiatric 
Association, 1994) include memory loss, deficits in executive function, visuo-spatial 
skills and attention, as well as impaired language, problem solving and reasoning 
ability These impairments can also impact on the quality of life, self-efficacy, 
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functional ability and mental health of people with dementia. There has been a 
wealth of research exploring the efficacy of cognitive-based interventions in the 
treatment of dementia, which focus on improving or stabilising cognitive symptoms. 
Such interventions are of value because despite wide-spread cognitive decline, some 
aspects of cognitive functioning, including some memory functioning can remain 
relatively stable and interventions which aim to maximise preserved functions have 
demonstrated successful outcomes. Whilst cognitive rehabilitation and training 
typically focus on improvement or maintenance of specific cognitive modalities, 
often at an individual level, cognitive stimulation is typically delivered in groups and 
adopts a more global approach, seeking to enhance general cognitive functioning, as 
well as social functioning (Clare & Woods, 2004). In his 1992 paper, Backman 
concluded that the use of well-designed cognitive stimulation interventions may have 
the potential to slow down the progression of dementia. Furthermore, a recent 
systematic review (Aguirre, Woods, Spector & Orrell, 2013) reported that cognitive 
stimulation interventions consistently result in positive outcomes for people with 
dementia with respect to their cognitive functioning, social interaction, 
communication and quality of life. Indeed, current NICE guidelines (NICE, 2007) 
recommend that:  
"People with mild/moderate dementia of all types should be given the 
opportunity to participate in a structured group cognitive stimulation 
programme. This should be commissioned and provided by a range of health 
and social care workers with training and supervision. This should be 
delivered irrespective of any anti-dementia drug received by the person with 
dementia." (p.216).  
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Involving Carers in Cognitive Stimulation 
Receiving a diagnosis of dementia can have an impact both on the person 
with dementia but also on their family members, especially those directly involved in 
caregiving. The impact of caring for a person with dementia is multifaceted, with 
negative consequences on physical and mental health, quality of life, self-efficacy, 
social support and financial stability frequently reported. These effects, referred to 
collectively as caregiver burden (Kasuya, Polgar-Bailey and Takeuchi, 2000), are 
described in more detail in the literature review of Cove (2013). High levels of 
caregiver burden can also result in poorer outcomes for the person with dementia, 
including decreased quality of life and early admission to nursing homes (Etters, 
Goodall & Harrison, 2008).  
Research has shown that involving carers in cognitive stimulation 
interventions for the person they care for can have positive benefits for both (Onder 
et al., 2005; Quayhagen and Quayhagen, 2001). Although not designed to offer direct 
intervention to carers, these studies aimed to involve carers in the delivery of 
cognitive stimulation. Benefits for people with dementia included improved memory, 
problem solving and verbal fluency, whilst carers experienced enhanced 
communication and interaction with the person they care for as well as maintenance 
of their quality of life and psychological well-being.  
Cognitive Stimulation Therapy 
Cognitive Stimulation Therapy (CST) is one version of cognitive stimulation 
(Spector et al, 2003). It is a brief, evidenced-based group therapy for people with 
mild to moderate dementia. The CST programme involves 14 sessions, lasting 
approximately 45 minutes, held twice weekly over seven weeks. The sessions cover 
a range of themes, with an emphasis on cognitive stimulation. CST is underpinned by 
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a set of eighteen key principles which guide all CST activity and aim to maximise the 
potential of people with dementia and build on their existing strengths. There is a 
focus on implicit rather than explicit learning and opinions not facts (a more detailed 
description is presented later in this paper).  
Development of CST 
CST was developed based on the findings of two Cochrane reviews of the 
research into psychological treatments for people with dementia, in particular Reality 
Orientation and Reminiscence (Spector, Orrell, Davies & Woods, 1998a; Spector, 
Orrell, Davies & Woods, 1998b). The CST programme was developed based largely 
on two concepts – Reality Orientation (RO) and Cognitive Stimulation, the 
therapeutic approaches found to have the best outcomes by the reviews. RO, 
described by Folsom (1968), was designed to improve memory and reduce confusion 
in people diagnosed with dementia. RO involves presenting orientation information 
to people with dementia about time, place or person in order to increase their 
understanding and recognition of their surroundings and thus also improve their self-
esteem and confidence. Cognitive Stimulation, described by Breuil et al. (1994), 
aims to stimulate encoding, consolidation and retrieval of information through global 
stimulation of cognitive functions.  
Evidence Base for CST 
An initial pilot study by Spector, Orrell, Davies & Woods (2001) 
demonstrated positive outcomes for people with dementia following participation in 
CST and resulted in some modifications to the original intervention. Based on these 
outcomes Spector et al. (2003) conducted a single blind, multi-centre randomised 
controlled trial to evaluate the modified CST programme. Two hundred and one 
people with dementia, from across 23 sites (residential homes and day centres) were 
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randomised to either the CST or control group (control groups continued with their 
usual daily activities whilst the CST groups took place). Results of this study 
demonstrated that those people with dementia receiving CST had a significantly 
better outcome in terms of both cognitive functioning and quality of life, although no 
benefits in communication, behaviour, global functioning, mood or anxiety were 
observed. In addition, the authors demonstrated that CST produced effects 
comparable to those achieved by acetyl cholinesterase inhibitor drugs.  
Further research has supported the findings of Spector et al. (2003), including 
studies by Knapp et al. (2006) who demonstrated that CST is cost-effective and 
Aguirre et al. (2013), who found that as well improvements to cognition and quality 
of life, CST had positive effects on the behaviour of people with dementia and was 
effective regardless of whether participants were taking acetyl cholinesterase 
inhibitor drugs. Hall, Orrell, Stott and Spector (2013) determined that the cognitive 
domains most influenced by CST were memory, comprehension of syntax and 
orientation, although their study used a small sample, one group pretest-posttest 
design. Finally, in a qualitative study exploring the impact of CST (Spector, Gardner 
& Orrell, 2011), people with dementia reported feeling more positive, relaxed and 
confident following CST.  They thought that sharing views broadened their outlook 
on life which they experienced as an achievement. Furthermore, they enjoyed the 
groups, found them fun and expressed the wish that the groups could have continued 
for longer. 
Carer Involvement in CST 
At present, CST does not include any formal carer involvement. However, 
qualitative data reveals that carers often feel frustrated at not knowing what happens 
in CST groups, often because the person they care for cannot recall much from the 
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group (Spector et al., 2011). Involving carers more formally would allow them to 
develop a greater understanding of CST and may potentially encourage them to 
apply some of the principles and activities of CST in their day-to-day interactions. 
Furthermore, it may allow people with dementia to receive a higher ‘dose’ of CST if 
carers do apply its principles and use CST activities between sessions. This might 
produce additional benefits for people with dementia in line with previous research. 
The Current Study 
Despite the demonstrable efficacy of CST, very little phase IV 
implementation work is currently being conducted to evaluate the effectiveness of 
CST in the ‘real world’ i.e. in naturalistic settings. Phase IV trials (Medical Research 
Council, 2008) are conducted after an intervention has been developed and its 
efficacy has been demonstrated. Typically in the form of an RCT, they aim to 
evaluate interventions that have been introduced into clinical practice. The only 
implementation work the author is aware of is that which forms part of Orrell et al.’s  
Support at Home – Interventions to Enhance Life in Dementia (SHIELD, 2013) 
programme which, in part, is evaluating the use of CST in the community. However, 
this project does not include any carer involvement and no results are currently 
available. Although CST was designed and evaluated as a seven week, 14 session 
programme, in practice many NHS services deliver the programme once a week over 
14 weeks, due to both time constraints and resource limitations. In addition, at 
present CST does not formally include any carer involvement and no previous study 
exploring the impact of including carer involvement in the programme has been 
found, making this a second important area for exploration.  
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Aims 
CST delivered once a week for 14 weeks appears to be common in practice 
but is yet to be evaluated. Therefore, the first aim of the current study was to 
establish its effectiveness using a Phase IV trial. In addition, a carer training 
programme was developed to provide carers with an overview of CST to a) educate 
them and b) give them the opportunity to apply its principles at home, should they 
wish to. The second aim of the current study was to evaluate whether additional carer 
training led to any benefits above and beyond weekly CST. 
Hypotheses 
1. Weekly CST will result in improved cognition, quality of life and quality 
of the caregiving relationship for people with dementia, compared to 
those receiving no treatment. 
2. Carer training in addition to CST will result in further improvements in 
cognition and quality of life as well as improved quality of the caregiving 
relationship for people with dementia, over and above those achieved 
following CST alone 
Method 
Joint project 
A joint study was conducted with Nicola Jacobi, Trainee Counselling 
Psychologist (City University). The current study examined the impact of once 
weekly CST and the additional impact of enhancing CST with a carer training 
programme, looking solely at outcomes for the participants with dementia. Jacobi 
(2013) investigated the impact on carers of participating in the carer training 
programme. She assessed carer burden, psychological well-being, perceived level of 
competence and the quality of the carer-patient relationship. She also evaluated the 
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carer training programme using qualitative focus groups in order to evaluate and 
develop the programme (see appendix C for an outline of the contribution of each 
trainee to the research process).  
Design 
A single blind, randomised control design was used, with three independent 
conditions – two treatment conditions and a control condition. In treatment condition 
one, people with dementia received 14 sessions of weekly CST and their carers 
received CST training (CST plus carer training). In treatment condition two, people 
with dementia received 14 sessions of weekly CST (CST only). The control 
condition was a waiting list group, people with dementia did not receive CST and 
their carers received no training. People with dementia were placed on the waiting 
list for CST and continued with their usual activities. Although participants in the 
control group were not asked to withhold from participating in any other 
interventions whilst on the waiting list the research team were not aware of any 
participant who did participate in another psychological intervention during this time. 
At the end of the study people with dementia in the control group were offered CST 
and carers of people with dementia in the CST and control group were offered 
session 1 of the carer training programme. The trial was single blind: assessors were 
blinded to treatment allocation. In an attempt to maximise blindness, participants 
were reminded not to reveal the group they were in before each assessment. It was 
not possible to conduct a double blind trial because, as in any psychosocial trial, 
participants could not be blind to the condition they were in. 
Randomisation 
Participants were randomised using the block method (Schulz & Grimes, 
2002) to achieve equal group sizes and using Random Allocation Software version 1 
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(Saghaei, 2004). Randomisation was done separately for each site to ensure 
participants did not have to travel further than necessary. Randomisation was 
conducted by the clinician who would be running the CST groups at a particular site. 
This clinician then informed participating dyads of their group allocation, arranged a 
date for the initial assessment and gave them details of CST group dates and carer 
training session dates where necessary.  
Setting 
Data collection took place across three sites within South Essex Partnership 
Trust (SEPT). At one site CST groups were already routinely offered to people with 
dementia and at the other two sites CST groups were set up for the purpose of this 
study. All CST groups were conducted in community settings with transport 
available for those who needed it. Carer training sessions were similarly conducted in 
community settings and care for the person with dementia was provided when 
needed, to facilitate their attendance. Although the same procedures were followed in 
each site (see below) the research did not run concurrently across sites and separate 
CST groups and carer training sessions were held for participants at each site.  
Participants  
People with dementia were recruited from three Memory Assessment Clinics. 
All people with dementia who had a) been through one of the Memory Assessment 
Clinics during the previous two years (or who were on the waiting list for CST), b) 
met the inclusion criteria and c) had a carer who met the inclusion criteria, were 
invited to take part in the study, along with their carer. 
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Inclusion Criteria 
Eligibility criteria were adapted from Spector et al. (2003) whose study helped to 
determine which people CST is most suitable for. People with dementia were eligible 
for participation if they: 
1. Met the Diagnostic and Statistical Manual of Mental Disorders, Fourth 
Edition (DSM-IV; APA, 1994) criteria for dementia of any type; 
2. Scored 18-30 on the Mini-Mental State Examination (MMSE; Folstein, 
Folstein & McHugh, 1975) indicating mild to moderate dementia. See section 
on outcome measures for a fuller description; 
3. Could speak English and had some ability to communicate and understand 
communication – a score of 1 or 0 on questions 12 and 13 of the Clifton 
Assessment Procedures for the Elderly – Behaviour Rating Scale (CAPE–
BRS; Pattie & Gilleard, 1979); 
4. Lived in the community (i.e. not in a residential setting); 
5. Were able to see and hear well enough to participate in the group and make 
use of most of the material in the programme; 
6. Could engage in group activity for at least 45 minutes; 
7. Did not have major physical illness or disability which could affect 
participation; 
8. Did not have a diagnosis of a learning disability; 
9.  Had a carer who was willing to take part in the study (and met inclusion 
criteria – see below). 
Point 2 was adapted to include those with an MMSE score of 18-30 as this fitted with 
the current inclusion criteria for CST used in the services where data collection took 
place. Point 9 was added to account for the inclusion of carers in this study. 
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The research team, which consisted of the author and Nicola Jacobi (Trainee 
Counselling Psychologist), Dr Aimee Spector (Senior Lecturer in Clinical 
Psychology) and Dr Helen Donovan (Consultant Clinical Psychologist) developed a 
set of inclusion criteria for carers to ensure that they  could participate fully in the 
research. Carers were considered eligible for participation if they: 
1. Had a minimum of three contacts per week with the person they cared for 
and were able to continue this for the period of the research study; 
2. Were aged 18 or above; 
3. Could speak English; 
4. Did not have major physical illness or disability which could affect 
participation. 
Power analysis  
As no previous research was found examining the effect of once weekly CST 
or carer involvement, it was not possible to calculate an a priori sample size. 
However, using G*Power 3.1 (Faul, Erdfelder, Lang, & Buchner, 2007) it was 
determined that a sample size of 144 participants (72 dyads), with power set at 0.80 
and using a 5% significance, would be adequate to detect an effect size of 0.34 or 
above. 
Procedure  
Recruitment 
For each of the three research sites, people with dementia and their carers 
(dyads) who met inclusion criteria were contacted to discuss the study. An 
information sheet for people with dementia and carers (appendix D) were sent to 
those who expressed an interest in participating. Dyads were given time to review 
this information (on average one week) before being contacted to determine if they 
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wished to participate. For those who agreed to participate, written informed consent 
was obtained, in accordance with the provisions of the Mental Capacity Act (2005), 
from both people with dementia and carers (see appendix E for consent forms) at the 
first assessment meeting. The General Practitioner of people with dementia was 
informed of their participation in the research (appendix F). 
Intervention: CST  
The study followed the standardised CST manual (Spector et al, 2005) used 
by health care professionals to deliver CST to people with dementia. Groups were 
held weekly for fourteen weeks, with sessions lasting approximately 45 minutes.  
One site already had an established CST programme. People were welcomed into the 
group, which was run by two facilitators. To enhance orientation a Reality 
Orientation (RO) board displayed orientation and group information such as the day, 
date, time, month and the group name (collectively chosen by the group during 
session 1). Sessions opened with the group song, again chosen collectively by the 
group in session 1, which was followed by a warm up exercise. Following this a 
news article was discussed by the group. The main activity then followed, based on 
that weeks’ theme. Themes included: physical games, childhood, using money, word 
association and food (see appendix G for full list of themes). Sessions were designed 
to be as inclusive as possible and activities were tailored to the groups’ abilities. 
Sessions closed with the group song. 
Intervention: Carer CST Training Programme 
Development of the Programme: The training programme was adapted from 
the current CST training programme and training manual (Making a Difference 2, 
Aguirre et al., 2011).  Adaptations were made based on the specific needs of this 
research project, drawing on the knowledge of the research team. An initial version 
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of session 1 of the training programme was piloted prior to the start of the research 
with a group of nine carers who had a family member with dementia who had 
recently attend a CST group. Feedback indicated that carers found the content of the 
training relevant. However, they thought the background information on dementia 
and the development of CST was too long and reduced the time they could spend 
learning about the content of CST sessions and how to apply its principles at home 
with the person they care for. Modifications were made based on the feedback from 
this pilot. The initial background information was condensed and links to websites 
providing more detailed information were provided in order to allow greater focus on 
the latter parts of the presentation. Further adaptations to the timing of the session 
were made following the delivery of the training at the first research site. 
Aims of the Programme: The aim of the CST carer training programme was 
not to train carers to deliver CST, but to provide them with training about the nature 
and rationale of CST, introduce essential skills around interacting with the person 
they care for and on implementing activities at home using the guiding principles of 
CST. The objective was to enhance the interactions between the carer and the person 
they care for in their home environment in such a way that carers felt empowered and 
could support the experience of the CST group for the person cared for.  
Overview of the Programme: Carers allocated to the CST plus carer training 
conditions were asked to attend two training sessions, with an optional workshop 
offered between these two sessions. The training was delivered in conjunction with 
the CST programme. Session 1 was a half-day session (three hours) and was 
delivered to coincide with people with dementia beginning CST. During this session 
carers were given an overview of dementia and of the development of and rationale 
for CST. The CST programme was outlined and details of individual session 
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presented. DVD clips from CST sessions taken from the Making a Difference 2 
manual (Aguirre et al., 2011) were also presented. Following this each of the 18 
guiding principles of CST (Table 1) was described and ways of engaging the person 
at home according to these principles were suggested. Carers were given a work 
book which outlined a selection of activities that related to each theme undertaken in 
the CST programme, which they could select to try with the person between CST 
sessions. Space was provided for carers to write down their own ideas for relevant 
activities and they were also encouraged to share their ideas with the group. The 
workbook also contained a diary and carers were asked to record any activities tried 
at home with the person they care for, along with ratings of the success of these 
activities. The workbook and diary were developed by the team based on previous 
experience of training programmes. Carers were given a copy of the training 
presentation and a copy of the Making a Difference 2 manual (Aguirre et al., 2011) 
to take away.  
Session 2 was delivered during the final week of the CST programme and 
lasted approximately 1 hour. The focus of this session was on maintenance of skills 
acquired into the future. A brief presentation was given to remind carers of the basic 
content of CST sessions and the underlying principles of CST. Time was given for 
answering questions and addressing concerns and to share ideas of successful 
activities used at home. An optional workshop was offered at week seven. This was a 
one hour question and answer session to give carers the opportunity to discuss any 
problems they were experiencing and to receive support if they would like, but was 
not compulsory. 
 
 
71 
 
Table 1 
The 18 key principles underlying CST 
 Key Principles 
 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
 
            Mental stimulation 
New ideas, thoughts and associations 
Using orientation, both sensitively and implicitly 
Opinions rather than facts 
Using reminiscence as an aid to the here-and-now 
Providing triggers to aid recall 
Continuity and consistency between sessions 
Implicit (rather than explicit) learning 
Stimulating language 
Stimulating executive functioning 
Person-centredness 
Respect 
Involvement 
Inclusion 
Choice 
Fun 
Maximising potential 
Building / strengthening relationships 
 
 
Assessments 
All participants were assessed at baseline (the two week period before the 
intervention) and at follow-up (the two week period after the intervention ended). 
Although participants were offered the choice of meeting with researchers at their 
home or at their local memory clinic, all participants elected to complete assessments 
at home. Wherever possible two researchers visited each dyad to conduct 
assessments so that assessments could run concurrently, therefore minimising the 
time commitment for dyads and ensuring people with dementia were not alone whilst 
carers completed assessments. Cares were asked to provide demographic details for 
themselves and for the person they care for at the first assessment. 
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Outcome measures 
The outcome measures for cognition and quality of life which showed 
sensitivity to change in previous CST research were selected (Spector et al., 2003). 
In addition, the quality of the person with dementia-carer relationship was assessed. 
This has not been previously assessed in CST trials as they have not included carer 
input. 
Cognition  
Two outcome measures were used to assess cognition – the Mini Mental 
State Examination (MMSE; Folstein et al., 1975) and the Alzheimer’s Disease 
Assessment Scale – Cognition (ADAS-Cog; Rosen, Mohs & Davis, 1984). The 
MMSE is a brief, 30 item test with good reliability and validity, assessing a range of 
cognitive functions including orientation, registration, attention and calculation, 
recall, language, repetition and complex commands. People with dementia score 1 
point for each correct response up to a total of 30, with a score of 0-10 indicating 
severe dementia, a score of 11-20 indicating moderate dementia and a score of 21 
and above indicating mild dementia (Folstein et al., 1975). The ADAS-Cog is a more 
comprehensive and extensive measure of cognitive function than the MMSE and one 
of the most commonly used assessments of cognition in clinical trials with people 
with dementia. Items cover word recall, naming, commands, constructional praxis, 
ideational praxis, orientation, word recognition, spoken language, comprehension, 
word-finding and remembering instructions. Scores range from 0-70 with higher 
scores indicating greater impairment. The ADAS-Cog has high reliability and 
validity (Rosen et al, 1984). 
 
 
73 
 
Quality of Life 
Quality of life for people with dementia was assessed using the Quality of 
Life – Alzheimer’s Disease scale (QoL-AD; Logsdon, Gibbons, McCurry & Teri, 
1999). The QoL-AD is a brief, 13-item questionnaire delivered in interview format. 
Response options, and where needed questions, were displayed for people with 
dementia to follow. People with dementia rate the quality of different aspects of their 
life. Questions cover the following domains: physical health, energy, mood, living 
situation, memory, family, marriage, friends, chores, fun, money, self and life as a 
whole. People with dementia rate each item on a four point scale whereby a rating of 
1= poor, 2=fair, 3=good and 4=excellent. Scores are in the range of 13-52, with 
higher scores indicating better quality of life. The QoL-AD has good internal 
consistency, validity and reliability (Thorgrimsen et al., 2003). 
Quality of the caregiving relationship  
The quality of the relationship between the person with dementia and their 
carer was assessed using the Scale for the Quality of the Current Relationship in 
Caregiving (QCRC; Spruytte, Van-Audenhove, Lammertyn & Storms, 2002). This 
scale is a 14 item measure assessing relationship quality, including level of criticism 
and level of warmth. The scale is delivered in interview format with response options 
and where needed questions, displayed for people with dementia to follow. Each 
item is in the form of a statement e.g. ‘I blame my relative for the cause of my 
problems’; ‘I feel very good if I am with my relative’. People with dementia rate the 
degree to which they agree or disagree which each statement on a five point scale 
(totally agree, agree, not sure, disagree, totally disagree). The maximum score is 70 
with high scores indicating good relationship quality. Good reliability and validity 
have been demonstrated (Spruytte et al., 2002).  
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Ethics 
Ethical approval for this study was granted by London South East National 
Research Ethics Service (NRES) Committee (appendix H). This committee is 
designated to review research involving adults who may lack capacity under The 
Mental Capacity Act (2005). The British Psychological Society (BPS; Dobson, 2008) 
sets out procedures for determining the capacity to consent for research participants. 
In this context, consent has to be regarded as a continuing process rather than a one-
off decision. An assessment of the capacity to consent to participate in the research 
of each person with dementia was undertaken at the start of the research and 
willingness to continue participating in the study was checked through discussion 
with the person with dementia and their carer during subsequent assessments. 
Participating carers were also asked to consent to the participation of the person they 
were caring for. The following procedures, based on the BPS criteria, were in place 
to manage any case where the capacity of a person with dementia was in doubt: 
1. Where the researcher has any doubts regarding the capacity of the person 
with dementia to provide informed consent, advice from an appropriate 
clinician will be sought. 
2. Where the person with dementia has previously given informed consent 
to participate, this will provide a good indication of their views regarding 
the research. 
3. All people with dementia participating will be doing so with the full 
involvement and assent of a family carer; the family carer will be able to 
withdraw the person with dementia from the study at any time. 
75 
 
4. A personal consultee (not a carer taking part in the research) will be 
invited to consider what they think the views of the person with dementia 
would have been, if they had capacity. 
5. Any person with dementia showing verbal or non-verbal indications of 
refusal or reluctance to participate in group sessions or assessment 
interviews will be withdrawn from the study. 
6.  Informed consent from the carer will be sought separately and they are 
not considered to be a vulnerable group. 
Data analysis 
The Statistical Package for Social Sciences (SPSS) version 17 was used to 
analyse data. Intention to treat analysis was applied using the last observation carried 
forward method for data missing at follow-up. Scores on the MMSE were found to 
be normally distributed. However, for the CST group baseline scores on the QoL-AD 
and QCRC showed significant skewness and kurtosis. For the control group, scores 
on the ADAS-Cog showed significant skewness and kurtosis at both time points. Z-
scores were calculated to check for outliers and subsequently 4 scores considered as 
extreme (a z-score of 3 or above) were replaced with the next highest or lowest score. 
Removal of these extreme scores rendered all outcome measure normally distributed 
and this was confirmed by calculations of residual scores and Cook’s Distance scores 
for each measure, all of which were within the accepted level needed to assume 
normality.  
One-way ANOVAs and χ2tests were used to check for differences in 
demographic characteristics between participants in three conditions at baseline. 
Outcome measures were analysed using mixed method ANCOVAs to evaluate the 
changes in scores over time and across conditions. Use of ANCOVA allows for 
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variability in baseline characteristics (covariates) to be controlled for. The age and 
gender of the people with dementia were entered as covariates. Effect sizes were 
calculated using Partial Eta
2 (p
2
). 
Results 
Recruitment and Attrition 
One hundred and sixty six dyads were identified as suitable for inclusion. Of 
these 122 consented to receive information packs and of these 72 consented to 
participate and were randomised into one of the three treatment conditions. Four 
dyads dropped out before the first assessment, therefore no data was available for 
these participants and they were not included in the final analyses. Nine dyads 
dropped out between the first assessment and follow-up. Figure 1 displays details of 
the flow of participants through the research. There were no significant differences in 
the proportion of completers and non-completers across the three conditions 
χ2(2)=1.042, p=0.594. Comparison of baseline characteristics of those who dropped 
out and those who did not revealed no significant differences. Baseline 
characteristics explored were age t(66)=-0.53, p=0.60, gender χ2(1)=0.03, p=0.87, 
diagnosis χ2(6)=4.92, p=0.56, carer age t(66)=-1.36, p=0.18, carer gender χ2(1)=0.52, 
p=0.47 and the scores of people with dementia on the four outcome measures: 
MMSE t(66)=0.73, p=0.47; ADAS-Cog t(64)=-1.47, p=0.14; QoL-AD t(66)=0.78, 
p=0.44; QCRC t(65)=-0.29, p=0.77. 
Participant Characteristics 
A description of the characteristics of people with dementia across the three 
conditions can be found in Table 2. Details of education were not consistently 
collected and are therefore not included. Across the whole sample approximately one 
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quarter of participants had moderate dementia (26.5%) and three quarters had mild 
dementia (73.5%). Two thirds of participants (67.6%) had a diagnosis of Alzheimer’s 
disease (early onset, late onset or mixed/atypical). The majority of participants were  
White British (86.8%) and lived in their own home (92.6%). It was most common for 
participants to be cared for by their spouse (75%) and the majority of participants 
had not previously attended any intervention related to their dementia (89.7%). Of 
the seven who had done so, three attended a music for memory group, two attended a 
Parkinson’s disease group, one attended an Alzheimer’s Society group and one 
participant specified only that they attended a non-therapy group. There were no 
significant differences across the three conditions in any of the participant 
characteristics. 77.8% of people with dementia assigned to receive CST attended 
more than half of the group sessions. There were no differences in the mean number 
of sessions attended by participants in the CST plus carer training and the CST 
conditions. 
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Figure 1 
Participant flow through the study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dyads referred and met 
inclusion criteria N=166 
Dyads received participant 
information sheets N=122 
Randomisation N=72 
CST plus carer training 
N=24 
 
CST N=24 Control N=24 
 
Withdrew N=3 
1 PwD died 
1 PwD became unwell 
1 change in family 
circumstances 
 
Withdrew N=0 
 
Withdrew N=1 
1 Change in family 
circumstances 
Completed 1st 
assessment N=21 
 
Completed 1st 
assessment N=24 
 
Completed 1st 
assessment N=23 
 
Withdrew N=4 
1 PwD became unwell 
3 Carer withdrew 
 
 
Withdrew N=3 
2 PwD withdrew from 
CST 
1 Carer withdrew 
 
Withdrew N=2 
1 PwD died 
1 Change in family 
circumstances 
 
Completed 2nd 
assessment N=17 
 
Completed 2nd 
assessment N=21 
 
Completed 2nd 
assessment N=21 
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Table 2 
Baseline characteristics of participants with dementia 
 CST plus 
carer 
training 
CST Control F/t/χ2 
value, p-
value 
Age, mean (sd) 75.4 (5.56) 76.8 (6.62) 77.8 (7.47) F=0.73 
p=0.49 
Gender 
  Male (%) 
  Female (%) 
 
11 (52.4) 
10 (47.6) 
 
15 (62.5) 
9 (37.5) 
 
10 (43.5) 
13 (56.5) 
χ2 =1.71 
p=0.43 
Ethnicity 
  White British (%) 
  White Irish (%) 
  White Other (%) 
  Black Caribbean (%) 
  Indian (%) 
 
17 (81.0) 
0 (0) 
2 (9.5) 
2 (9.5) 
0 (0) 
 
23 (95.8) 
0 (0) 
0 (0) 
0 (0) 
1 (4.2) 
 
19 (82.6) 
2 (8.7) 
0 (0) 
2 (8.7) 
0 (0) 
χ2 =12.78 
p=0.12 
Living Situation 
  Private Accommodation (%) 
  Sheltered Housing (%) 
  Supported Living (%) 
 
20 (95.2) 
0 (0) 
1 (4.8) 
 
20 (83.3) 
1 (4.2) 
3 (12.5) 
 
23 (100) 
0 (0) 
0 (0) 
χ2 =5.39 
p=0.25 
Dementia Diagnosis Sub-Type 
  Alzheimer’s disease (early onset) (%) 
  Alzheimer’s disease (late onset) (%) 
  Alzheimer’s disease (atypical/mixed) 
(%) 
  Vascular dementia (%) 
  Sub-cortical Vascular dementia (%) 
  Dementia in Parkinson’s disease (%) 
  Unspecified dementia (%) 
 
0 (0) 
15 (71.4) 
1 (4.8) 
 
0 (0) 
2 (9.5) 
0 (0) 
3 (14.3) 
 
0 (0) 
11 (47.8) 
2 (8.7) 
 
3 (13.0) 
1 (4.3) 
4 (17.4) 
2 (8.7) 
 
1 (4.3) 
10 (43.5) 
6 (26.1) 
 
1 (4.3) 
2 (8.7) 
1 (4.3) 
2 (8.7) 
χ2 =17.12 
p=0.15 
Dementia Severity 
Mild (%) 
Moderate (%) 
 
15 (71.4) 
6 (28.6) 
 
18 (75.0) 
6 (25.0) 
 
17 (73.9) 
6 (26.1) 
χ2 =0.08 
p=0.96 
Living with Carer 
  Yes (%) 
  No (%) 
 
18 (85.7) 
3 (14.3) 
 
19 (79.2) 
5 (20.8) 
 
19 (82.6) 
4 (17.4) 
χ2 =1.67 
p=0.85 
Relationship to Carer 
  Spouse (%) 
  Partner (%) 
  Mother/Father (%) 
  Mother/Father-in-law (%) 
  Aunt/Uncle (%) 
 
17 (81.0) 
0 (0) 
4 (19.0) 
0 (0) 
0 (0) 
 
17 (70.8) 
0 (0) 
5 (20.8) 
2 (8.3) 
0 (0) 
 
17 (73.9) 
1 (4.3) 
4 (17.4) 
0 (0) 
1 (4.3) 
χ2 =7.81 
p=0.45 
Age of Carer,  mean (sd) 68.81 
(10.39) 
67.13 
(11.26) 
70.43 
(11.12) 
F=0.54 
p=0.59 
No. of medications, mean (sd) 5.19 (4.14) 3.88 (2.62) 5.70 (4.16) F=1.53 
p=0.22 
Dementia Medication 
  Yes (%) 
  No (%) 
 
10 (47.6) 
11 (52.4) 
 
16 (66.7) 
8 (33.3) 
 
13 (56.5) 
10 (43.5) 
χ2 =1.67 
p=0.43 
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Attended previous dementia 
intervention 
Yes (%) 
No (%) 
 
 
1 (4.8) 
20 (95.2) 
 
 
3 (12.5) 
21 (87.5) 
 
 
3 (13.0) 
20 (87.0) 
χ2 =1.01 
p=0.60 
No. of CST sessions attended, mean 
(sd) 
10.95 
(3.64) 
10.50 
(4.53) 
N/A t=0.37 
p=0.72 
 
Carer Attendance at the Training Programme 
Although carer outcomes will be reported in full by Jacobi (2013) the level of 
attendance at the carer training programme is reported here. Of the 21 carers in the 
CST plus carer training condition, 14 (66.7%) attended all sessions (sessions 1, 2 and 
the optional workshop). Two (9.5%) attended sessions 1 and 2 but not the optional 
workshop, four (19%) attended session 1 only. In total 20 carers attended the first 
(and main) training session and one (4.8%) did not attend any sessions. Although 
carers were asked to record all CST activity they used at home, the majority of carers 
did not, meaning hardly any data about level of use of CST activities or principles 
were available. 
Analysis of Outcomes 
 There were no significant baseline differences across the three conditions on 
any of the outcome measures: MMSE, F(2,67)=0.16, p=0.85; ADAS-Cog, 
F(2,65)=0.05, p=0.96; QoL-AD, F(2,67)=0.69, p=0.51; QCRC, F(2,66)=0.22, p=0.81. 
Mean scores at baseline and follow-up for each outcome measure for each condition 
are displayed in Table 3, which also displays between-group effects and effect sizes 
from the ANCOVA analysis. 
There were no changes in cognition as assessed by the MMSE over time, 
F(1,63)=0.81, p=0.37 (p
2 
=0.01) and no significant differences between the three 
groups at follow-up, F(1,63)=0.84, p=0.92 (p
2
=0.003). Although there was a 
significant decline in cognition between baseline and follow-up across the whole 
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group as assessed by the ADAS-Cog, F(1,61)=4.38, p=0.04, this effect was very 
small (p
2
=0.07) and there were no between group differences on this measure at 
follow-up, F(1,61)=0.02, p=0.98 (p
2
=0.001). There were no between group 
differences on any of the 12 subscales of the ADAS-Cog. There were no changes in 
quality of life (QoL-AD) over time, F(1,61)=0.003, p=0.96 (p
2
=0.0001) and no 
differences between the three groups at follow-up, F(1,63)=0.82, p=0.44 (p
2
=0.03). 
Similarly, there were no changes in the QCRC over time, F(1,62)=1.68, p=0.20 
(p
2
=0.03) and no between group differences at follow-up, F(1,62)=0.97, p=0.39 (p
2 
=0.03).  
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Table 3 
Mean Scores at baseline and follow-up for each outcome measure 
 
 
Baseline Follow-Up 
ANCOVA 
between group 
difference 
p
2
 
 CST plus 
carer 
training 
CST Control CST plus 
carer 
training 
CST Control   
Mini-Mental State Examination 
 
 
22.33 
(3.54) 
22.71 
(3.76) 
22.91 
(3.01) 
22.19 
(4.48) 
22.38 
(4.75) 
22.13 
(3.40) 
F=0.84 
p=0.92 
0.003 
Alzheimer’s Disease Assessment 
scale – Cognition 
 
18.35 (7.1) 18.13 
(8.24) 
17.68 
(6.51) 
20.10 19.04 20.09 F=0.02 
p=0.98 
0.001 
Quality of Life – Alzheimer’s 
Disease scale 
 
36.43 
(6.06) 
36.42 
(5.44) 
34.78 
(5.43) 
36.45 35.65 35.32 F=0.82 
p=0.44 
0.03 
Scale for the Quality of the 
Current Relationship in 
Caregiving 
57.38 
(6.49) 
57.09 
(6.91) 
56.13 
(6.53) 
57.90 55.65 56.41 F=0.97 
p=0.39 
0.03 
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Discussion 
Summary of Findings 
 The current study aimed to determine the effects for people with dementia of 
delivering CST once a week for 14 weeks and to establish any additional benefits of 
enhancing weekly CST with a carer training programme.  However no improvements 
for people with dementia in their cognition, quality of life or the quality of the 
relationship with their carer were observed in groups who received either CST or 
CST plus carer training, when compared to the no treatment control group.  
Interpretation of Results 
The results demonstrate that delivering CST once a week for 14 weeks may 
not be an effective format. There is strong evidence for the efficacy of twice weekly 
CST and this format is recommended in the NICE guidelines (NICE, 2007). The 
current study does not provide any evidence that delivering a once weekly 
programme of CST is effective and as such leads to the conclusion that this format 
should not be utilised in practice. There is no indication that NICE guidelines should 
be amended to include a once weekly programme and as such services should offer 
twice weekly programmes. Twice weekly CST provides a more intensive treatment 
‘dose’ and this may be a necessary ingredient to ensure effective outcomes. Although 
the structure and content of the once weekly CST programme was the same as that 
utilised in the twice weekly paradigm, simply delivering the same programme with 
the same session content may not be sufficient to achieve change without the 
intensity of the session delivery. New learning or maintenance of existing capacities 
may require a more frequent level practice or repetition to be successful than once 
weekly CST is able to achieve. Twice weekly CST may provide the required dose to 
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achieve the learning that cognitive stimulation aims to achieve. Therefore, CST may 
simply not achieve its aims if delivered too infrequently. 
The results of the current study indicate that once weekly CST and a carer 
training programme do not have positive outcomes for people with dementia,. 
However, it is important to consider several other possible explanations of the result 
observed. 
Participants’ Level of Cognitive Functioning 
One explanation for the lack of positive outcomes observed is that people 
with dementia in the current study were already functioning at their optimum level, 
particularly in terms of their cognitive abilities. Cognitive functioning as assessed by 
the MMSE and the ADAS-Cog was higher in the present study than in previous trials. 
Mean MMSE scores in both the study by Spector et al. (2003) and that by Aguirre et 
al. (2013) were lower (14.4 and 16.7 respectively) than that observed in the current 
study (22.66). Similarly, on the ADAS-Cog people with dementia in the current 
study scored, on average, 18.05, compared with 27 and 34.4 in Spector et al. (2003) 
and Aguirre et al. (2013) respectively. According to the criteria set out by Folstein et 
al. (1975), using MMSE scores reveals that participants in the two previous studies 
were on average in the moderate range of dementia, whilst people with dementia in 
the current study were, on average, in the mild range. Previous studies may have 
observed improvements in cognition because people with dementia had already 
deteriorated to a level that gave scope for improvements.  
This conclusion is supported by Hall et al. (2013) who observed no change 
from baseline in cognition as assessed by the MMSE. The average baseline MMSE 
score in this study (20.3) was closer to that of the current study and supports the 
possibility that initial higher levels of cognitive functioning may not leave scope for 
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any improvements to be achieved. However, it is possible that the impact of CST 
continues to take effect, particularly for those people with dementia whose carers 
received CST training and who could effectively be receiving a longer term ‘dose’ of 
CST. As the current study did not include a long term follow-up assessment it is not 
possible to determine if such effects occur.  
Sensitivity of Outcome Measures 
A second possibility is that there were differences between the groups in the 
current study which were not adequately assessed. Although Hall et al. (2013) did 
not observe any improvement in cognition as assessed by the MMSE, they did 
observe some improvements in cognition on other measures. However, these were 
more comprehensive, domain specific measures than either the MMSE or the ADAS-
Cog. It could therefore be that ceiling effects on the MMSE and ADAS-Cog were 
observed in the current study, whilst more sensitive measures would have allowed 
differences to be detected. Furthermore, of the two previous studies which have 
measured quality of life, only one (Spector et al., 2003) found improvements 
following CST on the QoL-AD (the measure of quality of life used in the current 
study). Aguirre et al. (2013) found improvements in quality of life as assessed by the 
Dementia Quality of Life measure (DEMQOL; Smith et al., 2005) but not as 
assessed by the QoL-AD. The two measures may, the authors argue, be measuring 
two different aspects of quality of life. The current study therefore, may not have 
assessed all aspects of quality of life and could have missed improvements due to a 
limited assessment of this outcome.  
Range of Outcomes Assessed 
It is also possible that people with dementia experienced benefits following 
CST that were not measured in this study. The outcome measures used were selected 
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based on those for which Spector et al. (2003) found improvements in their study, 
meaning that no measures of communication, behaviour, global functioning, mood or 
anxiety were included. However, as stated there were differences in participants’ 
cognitive functioning between the current study and that of Spector et al. (2003) and 
the majority of participants in their study lived in residential settings whilst all 
participants in the current study were community based. It is therefore possible that 
people with dementia in the current study could have experienced positive outcomes 
in these domains, or other domains not assessed. For example, the qualitative study 
by Spector et al. (2011) revealed that people with dementia experienced a range of 
benefits following CST not assessed in the quantitative studies of Spector et al. 
(2003), Aguirre et al. (2013) and Hall et al. (2013), including increased confidence 
and sense of achievement. 
Validity of the Carer Training Programme 
One  possibility as to why the carer training programme appears to have been 
ineffective is that it was not substantial enough and failed to achieve its aims of 
providing people with dementia with a higher ‘dose’ of CST. The training 
programme was developed by the research team and modified based on limited 
feedback from a small pilot study and as such may not have been a good enough 
programme to achieve its aims. The maximum number of hours training received by 
carers was five and this may simply not have been enough to ensure any differences 
occurred in their interactions or activities undertaken with the person they care for. 
No data as to whether the training had successfully changed carers’ knowledge or 
behaviour were collected so it is not possible to determine whether the training 
programme was valid. 
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Changes in Carers’ Interactions with the Person they Care for 
A final possibility is that, even if the training programme was a valid and 
useful one, carers may not have implemented any changes in their interactions with 
the person they care for following the training. Almost no data was available as to 
the extent to which carers used any of the recommended activities or adapted their 
interactions according to the CST principles because the majority of carers did not 
fill in the weekly diary given to them to record such activity. One possibility then is 
that carers were not using the CST at home and therefore people with dementia in 
this group did not receive a higher ‘dose’ of the intervention than those in the CST 
group as planned. This does not explain why no positive outcomes from receiving 
CST were observed but may explain why involving carers in the intervention appears 
to have had no more impact for people with dementia than receiving CST alone. 
Even if carers did interact differently with the person they care for having learnt 
about dementia and the key principles of CST, it is possible that the outcome 
measures chosen were not appropriate to detect the impact of such changes for the 
person with dementia as the constructs assessed may not have been influenced by 
changes in carer behaviour. 
Methodological Limitations 
There were several limitations to the current study. Although attempts to 
ensure that all assessors were blind to participants’ group allocation were made, no 
formal measure of the integrity of the blinding process was included. One way to 
measure the integrity of blinding is to ask assessors to indicate which group they 
think a participant is in and how confident they are in this perception. As this was not 
done, it was not possible to determine the extent to which observer biases were 
introduced to assessments in the current study.  
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Secondly, no monitoring of treatment fidelity was undertaken, hence the 
extent to which CST sessions were implemented as planned and the consistency with 
which they were implemented is unknown. Adherence checks, for example the 
completion by facilitators of a checklist to measure adherence to the intervention at 
the end of each session, would have allowed for an estimation of the level of 
adherence to the CST programme to be made and thus increase confidence that the 
intervention received by people with dementia was the intended intervention. 
 Thirdly, although it was originally planned that the same assessor would 
complete baseline and follow up assessments for the same participants, in practice 
this was not possible. This was due to the availability of assessors and the loss of 
blinding of one assessor in particular meaning she was unable to complete the 
majority of follow up assessments. This introduces the possibility that systematic 
differences in the way assessors delivered assessments may have resulted in biases 
across participants’ pre and post assessments. However, given the proven inter-rater 
reliability of both the MMSE and ADAS-Cog the difference in assessors is unlikely 
to have resulted in significant bias in assessment outcomes. 
 Finally, although the study was powered to detect large effect sizes, the 
relatively small sample size may have meant it was under powered to detect smaller 
effects that exist.  
Clinical Implications 
 The evidence from this study suggests that weekly CST and enhancement of 
CST with the carer training programme should not be recommended in practice. 
There is clear evidence from past research that CST is an effective intervention for 
people with dementia when offered on a twice weekly basis and as such should 
continue to be offered by services in line with the NICE guidelines (NICE, 2007). 
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Many services currently offer CST on a once weekly basis, whereas the findings of 
this study would not support such a mode of delivery at present. However, within 
South Essex Partnership Trust (SEPT) one service (included in the current study) that 
routinely offers CST on a weekly basis has noted, through routine monitoring of 
outcomes, improvements in the quality of life of people with dementia who attend 
weekly CST. Although no formal evidence is available this anecdotal evidence offers 
some support for the use of once weekly CST. Furthermore, participants in the 
current study frequently reported how much they had enjoyed going to the groups 
and expressed the wish that the groups could continue. Groups appear to offer a 
lifeline to many participants by providing a chance to make connections with others 
and an opportunity to share experiences and feel less isolated. The low attrition rate 
from CST groups also points towards participants experiencing some benefits of 
attending and CST groups may be more cost effective than other available services. 
Thus, it should not simply be concluded that CST delivered once a week with or 
without carer training is ineffective.  
Nevertheless, at present services setting up new CST groups should consider 
carefully whether to run them once or twice weekly. This should involve a 
consideration of both the above evidence and NICE guidelines alongside the 
practical issues, such as time, resources and participant availability, of running 
groups on a twice weekly basis. Services currently delivering weekly CST should 
consider changing their programme to a twice weekly format. If this is not feasible 
services should undertake service level monitoring of outcomes to ensure that those 
who participate are benefiting, to provide justification for delivering CST in this 
format given the evidence from the present study and to provide service-level data 
that can be used to further explore the effectiveness, or not, of weekly CST. The 
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impact for people with dementia of including carer training should similarly be 
monitored and assessed. 
Implications for Research 
 The findings of the current study were in contrast to those of previous 
research indicating the effectiveness of CST and of service level observations of the 
effectiveness of once weekly CST. It is therefore recommended that the current study 
be replicated using a wider range of outcome measures to capture possible benefits 
missed in the current study, for example mood, communication and behaviour. At the 
same time, a qualitative study with people with dementia to explore the impact of 
once weekly CST, for example the impact on participants’ daily lives, confidence, 
self-efficacy and sense of achievement, could be considered. This would allow a 
more subjective exploration of the benefits of once weekly CST and weekly CST 
enhanced with carer training. Including a cost-effective analysis in future research 
would facilitate a comparison with other services to determine whether CST offers a 
lower cost alternative to such services. 
Further development of the carer training programme will also be of benefit. 
We developed the carer training programme to be a brief, low intensity intervention 
and to see if this would provide an increased ‘dose’ of CST for people with dementia. 
As this appears not to have been the case a more intensive programme may be 
necessary to achieve the desired effects.  The development and evaluation of such a 
programme should form a focus of future research efforts. As part of the wider 
research project that the current study formed a part of, a qualitative analysis of 
carers’ experiences of the CST training programme was undertaken. The outcomes 
of this evaluation alongside a review of relevant literature, a consensus conference 
and consultation with service users should be combined to enable the development of 
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the programme to take place.  As well as evaluating this alongside weekly CST, this 
could be evaluated alongside twice weekly CST to determine whether carers can 
maintain the observed benefits of twice weekly CST in the longer term. The validity 
of the programme should be explored, for example through the use of measures of 
carers’ knowledge of dementia.  
Conclusion 
There is no evidence from this study to suggest that weekly CST is effective 
or that enhancing CST with carer training offers additional benefits to people with 
dementia. Whilst services should exercise caution if offering CST in a weekly 
programme and consider changing to offer a twice weekly programme, continued 
collection of outcome data will allow for ongoing monitoring of the progress of 
participants to ensure benefits are being achieved and would also contribute to the 
further evaluation of weekly CST. Further research should explore other outcomes 
and include a qualitative exploration of the benefits for people with dementia of 
weekly CST and weekly CST enhanced with a carer training programme. 
92 
 
References 
Aguirre, E., Spector, A., Streater, A., Hoe, J., Woods, B., & Orrell, M. (2011).  
Making a Difference 2. Hawker Publications: UK. 
Aguirre, E., Hoare, Z., Streater, A., Spector, A., Woods, B., Hoe, J., & Orrell, M.  
(2013). Cognitive Stimulation Therapy (CST) for dementia – who benefits 
most? International Journal of Geriatric Psychiatry, 28: 284–290.  
Aguirre, E., Woods, B., Spector, A., & Orrell, M. (2013). Cognitive stimulation for  
dementia: A systematic review of the evidence of effectiveness from 
randomised controlled trails. Ageing Research Reviews, 12, 253-262. 
American Psychiatric Association. (1994). Diagnostic and Statistical Manual of  
Mental Disorders. (4th ed.). Washington, DC: American Psychiatric 
Association. 
Backman, L. (1992). Memory training and memory improvement in Alzheimer’s  
disease: Rules and exceptions. Acta Neurologica Scandinavica: Supplement, 
139, 84-89. 
Breuil, V., De Rotrou, J., Forette, F., Tortrat, D.,Ganansia-Ganem, A., Frambourt,  
A., Moulin, F., & Boller, F. (1994). Cognitive stimulation of patients with 
dementia: Preliminary results. International Journal of Geriatric Psychiatry, 
9, 211-217. 
Clare, L., & Woods, R.T. (2004). Cognitive training and cognitive rehabilitation for  
people with early-stage Alzheimer’s disease: A review. Neuropsychological 
Rehabilitation, 14, 385–401. 
Cove, J. (2013). The effectiveness of combined interventions for people with  
93 
 
dementia and their carers. Unpublished Clinical Psychology Doctoral Thesis. 
Clinical, Education and Health Psychology Department: University College 
London. 
Department of Health (2007). National Service Framework for Older People. DH:  
London. 
Dementia 2012: A National Challenge. London: Alzheimer’s Society. 
Dobson, C. (2008). Conducting research with people not having the capacity to 
consent to their participation: A practical guide for researchers. Leicester: 
British Psychological Society. 
Etters, L., Goodall, D., & Harrison, B.E. (2008). Caregiver burden amongst dementia  
carergivers: A review of the literature. Journal of the American Academy of 
Nurse Practitioners, 20, 423–428. 
Faul, F., Erdfelder, E., Lang, A., & Buchner, A. (2007). G^* Power 3: A flexible  
statistical power analysis program for the social, behavioral, and biomedical 
sciences. Behavior Research Methods, 39, 175. 
Folsom, J. C. (1968). Reality orientation for the elderly mental patient. Journal of  
Geriatric Psychiatry, 1, 291–307. 
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). Mini-mental state: A  
practical method for grading the cognitive state of patients for the clinician. 
Journal of Psychiatric Research, 12, 189-198.  
Hall, L., Orrell, M., Stott, J., & Spector, A. (2013). Cognitive Stimulation Therapy  
(CST): Neuropsychological mechanisms of change. International 
Psychogeriatrics, 25, 479-489.  
Jacobi, N. (2013). The impact of enhancing Cognitive Stimulation Therapy (CST)  
94 
 
with a carer training programme: Outcomes for carers and results of a 
qualitative evaluation of the training programme. Unpublished Counselling 
Psychology Doctoral Thesis. School of Social Sciences: City University. 
Kasuya, R. T., Polgar-Bailey, P., & Takeuchi, R. (2000).Caregiver burden and  
burnout: A guide for primary care physicians. Postgraduate Medicine, 108, 
119–123. 
Knapp, M., Thorgrimsen, L., Patel, A., Spector, A., Hallam, A., Woods, B., &  
Orrell, M.(2006). Cognitive stimulation therapy for people with dementia: 
Cost effectiveness analysis. British Journal of Psychiatry, 188, 574–580. 
Logsdon, R., Gibbons, L. E., McCurry, S.M., & Teri, L. (1999). Quality of life in  
Alzheimer’s disease: Patient and carer reports. Journal of Mental Health and 
Aging, 5, 21-32. 
Medical Research Council (2008). Developing and Evaluating Complex  
Interventions: New Guidance. London: MRC Health Services and Public 
Health Research Board. 
Mental Capacity Act (2005). London: Stationery Office. 
NICE-SCIE. (2007). Dementia: Supporting people with dementia and their carers in  
health and social care. NICE Clinical Guideline 42. London: National 
Institute for Health and Clinical Excellence. 
Onder. G., Zanetti, O., Giacobini, E., Frisoni, G., Bartorelli, L., Carbone, G.,  
Lambertucci, P., Silveri, M., & Bernabei, R. (2005). Reality orientation 
therapy combined with cholinesterase inhibitors in Alzheimer’s disease: 
Randomised control trial. British Journal of Psychiatry, 187, 450-455. 
Orrell, M., Spector, A., Thorgrimsen, L., & Woods, B. (2005). A pilot study  
95 
 
investigating the effectiveness of maintenance Cognitive Stimulation Therapy 
(MCST) for people with dementia.  International Journal of Geriatric 
Psychiatry, 20, 446-451.  
Orrell, M. (2013). Support at Home – Interventions to Enhance Life in Dementia  
(SHIELD). Retrieved from http://www.ucl.ac.uk/shield 
Pattie, A.H., & Gilleard,C. J. (1979) Clifton Assessment Procedures for the Elderly  
(CAPE). Sevenoaks: Hodder  & Stoughton. 
Quayhagen, M., & Quayhagen, M. (2001). Testing of a cognitive stimulation  
intervention for dementia caregiving dyads. Neuropsychological 
Rehabilitation. 11, 319-332. 
Rosen,W.G., Mohs, R.C. & Davis, K. L. (1984). A new rating scale for Alzheimer’s  
disease. American Journal of Psychiatry, 141, 1356-1364. 
Saghaei, M. (2004). Random allocation software for parallel group randomized trials.  
BMC Medical Research Methodology, 4, 26. 
Schulz, K. F., & Grimes, D. A. (2002).  Generation of allocation sequences in  
randomised trials: Chance, not choice. The Lancet, 359, 515-519 
Smith, S. C., Lamping, D. L., Banerjee, S., Harwood, R., Foley, B., Smith, P., Cook,  
J.C., Murray, J., Prince, M., Levin, E., Mann, A., & Knapp, M. (2005). 
Measurement of health-related quality of life for people with dementia: 
Development of a new instrument (DEMQOL) and an evaluation of current 
methodology. Health Technology Assessment, 9, 1–112. 
Spector, A., Orrell, M.; Davies, S., & Woods, B. (1998a). Reality Orientation for  
dementia: A review of the evidence for its effectiveness. Cochrane Library, 
Issue 4. Oxford: Update Software. 
Spector, A., Orrell, M.; Davies, S., & Woods, B. (1998b). Reminiscence therapy in  
96 
 
dementia. The Cochrane Database of Systematic Reviews. Oxford: UK. 
Spector, A., Orrell, M., Davies, S., & Woods, B. (2001). Can Reality Orientation be  
rehabilitated? Development and piloting of an evidence based programme of 
cognitive-based therapies for people with dementia. Neuropsychological 
Rehabilitation 11, 377-397. 
Spector, A., Thorgrimsen, L., Woods, B., Royan, L., Davies, S., Butterworth, M.,  
& Orrell, M. (2003). Efficacy of an evidence-based Cognitive Stimulation 
Therapy programme for people with dementia: Randomised controlled trial. 
British Journal of Psychiatry, 183, 248–254. 
Spector, A., Gardner, C., & Orrell, M. (2011). The impact of Cognitive Stimulation  
Therapy groups on people with dementia: Views from participants, their 
carers and group facilitators. Ageing and Mental Health, 15, 945-949. 
Spruytte, N., Van-Audenhove, C., Lammertyn, F. & Storms, G. (2002). The quality  
of the caregiving relationship in informal care for older adults with dementia 
and chronic psychiatric patients. Psychology & Psychotherapy: Theory, 
Research & Practice, 75, 295-311. 
Thorgrimsen, L., Selwood, A., Spector, A., Royan, L., Lopez, M. M., Woods, B., &  
Orrell, M. (2003). Whose quality of life is it anyway? The validity and 
reliability of the Quality of Life - Alzheimer’s Disease (QOL-AD) scale. 
Alzheimer’s Disease and Associated Disorders, 17, 201–208. 
 
 
 
97 
 
Part 3: Critical Appraisal 
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Overview 
This review will reflect on two aspects of the research process. Firstly, given 
that the results described in Part 2 (Cove, 2013a) were all non-significant, I will 
discuss factors that must be considered when interpreting non-significant findings 
and the ethical obligations of disseminating non-significant results. Secondly, I will  
evaluate the methodological quality of the RCT described in Part 2 (Cove, 2013a), 
based on knowledge I have developed through conducting this RCT and assessing 
the quality of RCTs included in the literature review (Cove, 2013b). The evaluation 
will consider aspects of the study that contribute and detract from its overall validity 
and provide a quality rating according to The Jadad Scale (Jadad et al., 1996). 
Non-Significant Research Findings 
 The results found in the RCT described in Part 2 (Cove, 2013a) were, to a 
certain extent surprising. Twice weekly CST has proved to be effective and service-
level evidence suggests that people with dementia experience at least some positive 
effects following once weekly CST. It was therefore hypothesised that weekly CST 
would be effective and that enhancing CST with carer training would provide an 
even greater ‘dose’ of CST, thus resulting in increased benefit above that achieved 
by CST alone. The fact that all findings were non-significant was therefore 
unexpected. This raised two important questions in my mind. Firstly, how should 
non-significant findings in research be interpreted?  Secondly, what are the 
implications of publishing or not publishing these findings?  
Interpreting Non-Significant Research Findings 
Failure to Reject the Null Hypothesis 
My immediate thought when considering the outcomes of my research was to 
conclude that the non-significant results meant that weekly CST, with or without 
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training for carers, is not an effective intervention for people with dementia. 
Therefore, in relation to my hypotheses I should reject the alternative hypothesis and 
accept the null hypothesis that no group differences would be observed. However, I 
considered the fact that in any research, failure to reject the null hypothesis (as in my 
study) is not the same as accepting the null hypothesis. Inferential statistics tell us the 
probability that our results occurred by chance. When a study finds a non-significant 
result all we can say with confidence is that the results of that particular study 
provide no evidence for the effectiveness of the intervention tested. We cannot say 
for certain that it does not work. This an important distinction and reflects the reason 
why, although I could not conclude that weekly CST for people with dementia and 
CST enhanced with carer training are effective interventions, I did not then simply 
conclude that they are ineffective. The results of my research told me only that, on 
the basis of the results, the probability of weekly CST with or without carer training 
being an effective intervention for people with dementia is low at present.  
In order to confirm (of refute) research findings and ensure they have not 
occurred by chance, research must be replicated to allow conclusions to be 
confidently accepted (Flay et al., 2005). This is why I included this as a 
recommendation in Part 2. Replication is an essential aspect of scientific research 
and is necessary in order to ensure that observed outcomes did not occur by chance. 
My confidence in the results I observed was limited by the fact that it was the first 
study of this nature and without replication it is not possible to conclude that the 
intervention is ineffective with confidence.  
Considering Competing Explanations for Observed Outcomes 
As well as being cautious when declaring an intervention ineffective on the 
basis of a non-significant and non-replicated result, it is also important to consider 
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alternative explanations as to why a non-significant result was observed. For the 
most part these considerations relate to methodological issues such as poor study 
design, inadequate sample size (and the resultant lack of power) and the effect of 
confounding variables. However, as Hewitt and Mitchell (2008) have highlighted, it 
is tempting when discovering a non-significant result to succumb to interpretive bias. 
This occurs when results are underemphasised by, for example, highlighting the 
limitations of a study as the reason for the lack of significant findings. Simply listing 
any reason any study may have found a non-significant result without proper 
consideration of the specific factors pertinent to a specific study is misleading to the 
reader. However, failure to consider competing explanations for observed effects 
may also be misleading. A careful consideration of both the evidence from the study, 
what is already known about the field and the limitations of the study is needed when 
drawing conclusions.  
These principles were applied in my own discussion. Only reasonable 
explanations for the observed findings were discussed, although it was tempting to 
list all possible sources of bias in an attempt to show that it was these that produced 
the non-significant finding. For example, discussion about possible confounding 
variables between groups was not included because use of randomisation should 
eliminate such bias and analysis of baseline variables confirmed the success of the 
randomisation. I attempted to present a balanced and realistic consideration of the 
results based on comparisons with previous research and identified methodological 
issues directly relevant to the study. 
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Disseminating Non-Significant Findings 
Publication Bias 
 A common reaction to research yielding non-significant results is that of 
disappointment, the implication being that such results are less important than 
significant results. One reaction I noticed to my own non-significant results was “that 
is a shame”. This led to me to consider further the implications of disseminating non-
significant research outcomes because my own reaction had been more along the 
lines of ‘that’s unexpected” given what we had been predicting but I did not think the 
results were unimportant.  On the contrary, lack of support for once weekly CST may 
have important implications for how services deliver CST programmes, particularly 
if the findings are replicated in future research. However, it appears that there is a 
bias towards proclaiming statistically significant results important and statistically 
non-significant results unimportant. Scargle (2000) has stated that “The literature of 
social sciences contains horror stories of journal editors and others who consider a 
study worthwhile only if it reaches a statistically significant, positive conclusion; that 
is, an equally significant rejection of a hypothesis is not considered worthwhile” 
(p.93). This attitude is reflected in what has been referred to as publication bias, 
defined by Abaid, Grimes and Schulz (2007) as the “selective publishing of research 
that yields favourable or statistically significant results” (p.339). Several review 
studies (Easterbrook, Berlin, Gopalan & Matthews, 1991; Hopewell, Loudon, Clarke, 
Oxman & Dickersin, 2009)  retrospectively following up all research approved by a 
chosen Research Ethics Committee within a particular time period found that 
research yielding statistically significant results was more likely to be published.  
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Implications of Publishing or not Publishing Non-Significant Results 
I considered the reasons I may have for not publishing my own research. My 
primary concern was that the findings may be interpreted to mean that once weekly 
CST categorically does not work. As already stated there are important 
considerations to make when interpreting any research findings. Whilst I have 
attempted to present these in Part 2 of this thesis I was concerned that if the results 
were taken in isolation, negative conclusions about weekly CST which are not 
confirmed at this stage could influence decisions about service delivery. Similarly, 
given the current NHS focus on evidence-based practice whereby commissioning of 
services is often based on proven effectiveness, these non-significant findings could 
potentially jeopardise current service provision. If commissioners are looking to the 
research for evidence of the effectiveness of weekly CST, the non-significant 
findings of this study may contribute to the decision making on the continuation of 
existing services. As stated, any judgements based on these findings would be 
premature given that they are yet to be replicated.   
However, it is clear that the non-publication of research which yields results 
that are not statistically significant means that literature which is published is a 
biased sample. As such, scientific conclusions, service development and direction of 
future research based on this literature are also likely to be biased. I considered the 
specific implications of failing to disseminate my own research findings. Firstly, the 
results of my study may provide valuable information about the psychological 
treatment of dementia. Failure to publish these findings means that knowledge as to 
the most effective interventions for this group will be limited. Secondly, given the 
emphasis within psychology practice for service provision to be evidence-based, 
failure to share my results places limits on the evidence from which those planning 
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services can draw. If weekly CST is indeed ineffective, this evidence must be made 
available. Clinical decision making may be unreliable and invalid if non-significant 
findings are not reported. Thirdly, from a research perspective, published research 
can help shape the direction of future research. Given that I have recommended that 
my study be replicated to provide greater confidence in the results, if I do not 
disseminate my research this recommendation will go undetected. It is also important 
to note that if future studies confirm the findings of my study, these should also be 
published to ensure that studies do not continue to repeat research which consistently 
shows no significant outcomes.  
My conclusion has been that all research, including my own, regardless of the 
outcome is important, whether it be to add to the scientific knowledge base, provide 
information for service-level decisions or guide the direction of future research. The 
key is for research to be reported honestly and without bias and for non-significant 
results not simply to be declared in-significant and thus ignored.  
Consideration of the Quality of the Research 
Assessment of the methodological quality of any research is essential to allow 
a judgement as to the validity of the research findings. Jadad et al. (1996) define 
quality in relation to a research study as “the likelihood of the trial design to 
generate unbiased results” (p.2). Poorly conducted research is more likely to yield 
biased results whilst high quality research yields results in which the reader can be 
more confident. Although I have already presented a consideration of the limitations 
of the research I conducted in Part 2 (Cove, 2013a), these are summarised below. I 
will now also consider the strengths of the research in more detail so as to provide an 
overall conclusion as to the quality of this study. 
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Strengths 
Randomisation 
A randomised controlled trial was chosen as this is accepted to be the ‘gold 
standard’ i.e. the most scientifically rigorous design for assessing the effectiveness of 
an intervention. By randomly assigning participants to the research conditions I was 
able to reduce the chance of selection bias and the occurrence of confounding 
variables. This is because influences on participants in the different groups should be 
equal and not differ across groups following randomisation. This increases the 
internal validity of the study. Furthermore, inclusion of a control group meant that 
any effects on participant outcomes other than the intervention, e.g. natural 
improvements, the Hawthorne effect etc., were controlled for.  
I consider the method of randomisation chosen to be the most suitable given 
the resources available, as it was both replicable, unpredictable and not open to 
control by the researchers. Ideally randomisation should be conducted by trial units 
completely unconnected to a research study in order to ensure complete impartiality; 
however, this was outside the scope of my research. Success of the randomisation 
process was confirmed through statistical analysis. There were no baseline 
differences in either the demographic or clinical characteristics of people with 
dementia at baseline so I could be confident that sampling error had been minimised. 
However, I still elected to use Analysis of Covariance (ANCOVA) to control for the 
age and gender of people with dementia so that chance variations between treatment 
conditions were controlled for.  
Description of Participants and Recruitment Process 
I included a description of participant characteristics and of the recruitment 
process which I consider to be suitably detailed. Both these factors increase the 
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quality of my research because they allow generalisation of the findings. Without a 
detailed description of participants and where they have been drawn from, it is not 
possible to determine to whom we may generalise the findings. It should be noted 
that although a detailed description of carer characteristics was not included, these 
are described in detail by Jacobi (2013). 
Blinding of Assessors 
The quality of the research trial was strengthened through the use of assessors 
blind to participant group allocation, which reduces the chance of bias in the 
assessment of outcomes, specifically measurement bias. It is ideal to also ensure that 
participants are masked with respect to treatment allocation. However, in trials 
investigating psychological interventions this is rarely possible and there was no way 
to achieve this in my trial.  
Rate of Attrition and Description of Dropouts 
A further factor that improved the overall quality of the study was the low 
attrition (dropout) rate observed. High levels of participant dropout can result in 
threats to the internal validity of a study, particularly if reasons for dropout are non-
random or if the rate of dropout differs across conditions. A review of reasons for 
why participants in my research dropped out revealed no systematic reasons for 
attrition related to the design or outcomes of the study. Furthermore, there were no 
differences in the characteristics of those who dropped out across all three conditions. 
In addition, the rate of attrition was low overall, suggesting a high level of 
acceptability of the intervention. This is further confirmed by the high level of 
compliance to the CST groups by those who were allocated to attend, with no 
differences in compliance between the CST and CST plus carer training groups. By 
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reporting compliance rates I allow the reader to make judgements as to the 
acceptability of CST.  
Intention to Treat Analysis 
I elected to use Intention to Treat (ITT) analysis in order to strengthen the 
quality of my research. ITT holds that all participants entered into a trial should be 
included in the final analysis. This is in order to avoid biases in the statistical 
analysis caused as a result of different attrition rates across groups, which leads to 
biases in estimates of the impact of an intervention (Flay et al., 2005). These authors 
report that biases in statistical tests can still occur even if rates of attrition across 
treatment conditions do not differ significantly. For this reason I still applied the 
principles of ITT to my data analysis. I believe that use of the last measurement 
carried forward technique to provide data for those who dropped out was suitable as 
the low rate of attrition meant I would not be including a high number of unverifiable 
measurements yet would still maintain a complete data set. 
Weaknesses 
The weaknesses of the research have mostly been described in Cove (2013a). 
In summary, no monitoring of treatment fidelity was undertaken; the study may have 
lacked power to detect smaller effects; pre and post assessments were not always 
completed by the same assessor and the degree to which assessors remained unbiased 
is unknown as this was not assessed. From my own experience I did find that despite 
being asked not to tell me which group they were in, participants did sometimes 
inadvertently do so by, for example, saying ‘I really enjoyed going to the groups’ or 
‘I haven’t had anything yet’. However, it is my judgement that the majority of 
participants did not reveal their group allocation. No long-term follow-up 
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assessments were included, meaning that any longer term effects could not be 
monitored.  
Quality Rating  
Using the Jadad Scale (Jadad, 1996) I was further able to rate the quality of 
my research study by obtaining a quantitative estimate of quality. The Jadad Scale 
rates the quality of RCTs based on three criteria: randomisation, blinding and 
dropouts. These criteria are described in Appendix A. As psychological research is 
not able to include participants blind to treatment allocation, my study was rated out 
of 4 rather than 5. 
Randomisation 
   I consider my method of randomisation to be appropriate because each 
participant had the same chance of being allocated to each condition and 
investigators had no way of predicting which participant would be allocated to which 
condition as a computerised method of randomisation was used. I therefore suggest a 
score of 2/2. 
Blinding 
The criterion for single blinding was met as the method I used was 
appropriate and described in the paper. I considered it appropriate because assessors 
did not know which condition participants had been allocated to and could not 
identify this. I suggest a score of 1/1 for this criterion, although this could be refuted 
as no confirmation of the success of the blinding is available. 
Dropouts 
In order to achieve the maximum score of 1 for this criterion, the research 
must state the number of dropouts from each treatment condition and report the 
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reasons for these, both of which I did and I therefore believe a score of 1/1 is 
appropriate for this criterion. 
 According to the Jadad Scale I rated my research study with a score of 4/4 
suggesting that it is of high quality. I have adopted the same strategy to rate my own 
research as I used to rate the RCTs in my literature review (Cove, 2013b). Although 
there are several weaknesses in the methodology of my study there are also many 
strengths and I therefore consider the research I have conducted to be of high quality, 
with minimal biases and therefore a high chance that the results produced were also 
unbiased. 
Conclusions 
The process of conducting both a literature review and an RCT has allowed 
me to gain a broader understanding of all the elements that are necessary to produce 
good quality research. Furthermore, the process of conducting a literature review has 
allowed me to recognise the limitations placed on the validity of outcomes of poor 
quality research. The need for good quality research in order to provide unbiased 
results is paramount. My knowledge of the factors to consider when designing, 
conducting and reporting an RCT to ensure it is of the highest possible quality has 
been greatly enhanced through first-hand experience. The importance of carefully 
interpreting and publishing all results, regardless of whether they are significant or 
not has been highlighted and the effects of not doing so have given me greater 
confidence in the need to publish my own findings, despite their lack of statistical 
significance. I consider my research findings to be non-significant not in-significant. 
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Appendix A 
The Jadad Scale - Scoring Criteria for Randomised Controlled Trials 
The Jadad Scale is a three-item, five-point questionnaire used to rate the quality of 
randomised controlled trials. Each question must be answered with a yes or no. Each 
yes scores one point and each no scores zero points. 
The questions are as follows:  
1. Was the study described as randomized? 
2. Was the study described as double blind? 
3. Was there a description of withdrawals and dropouts? 
To receive the corresponding point, an article should describe the number of 
withdrawals and dropouts, in each of the study groups, and the underlying reasons.  
Additional points were given if: 
 The method of randomisation was described in the paper, and that method 
was appropriate. 
 The method of blinding was described, and it was appropriate. 
Points would however be deducted if 
 The method of randomisation was described, but was inappropriate. 
 The method of blinding was described, but was inappropriate. 
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Appendix B 
York Centre for Systematic Reviews criteria for reviewing non-randomised trials 
 
Non-randomised research studies were rated on an eight-item scale based on criteria 
from the York Centre for Systematic Reviews: 
 
1. Was there adequate description of participants? 
2. Was there adequate description of an intervention and who received it? 
3. Is measurement likely to be reliable and valid? 
4. Are the measures used the most relevant ones for answering the research 
question? 
5. What was the drop-out rate and has this introduced bias? 
6. Is the length of time long enough to identify changes in the outcome of 
interest? 
7. In studies where two groups are compared are the groups similar? Were they 
treated similarly? And if not were there attempts to control for those 
differences 
(matching or statistical control)? 
8. Was outcome assessment blind to exposure status? 
 
In this review studies that met all of the criteria were rated as good. Those that met 
more than half the criteria were rated as adequate and those that met less than half 
the criteria were rated as poor. 
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Appendix C 
Trainees’ Contribution to the Joint Research Project 
 
The design of the research study, ethics application and development of project 
materials was conducted jointly by both trainees. Nicola Jacobi identified 
participants who met inclusion criteria and recruitment was then conducted jointly. 
Baseline assessments were carried out jointly by both trainees with support from 
assistant psychologist working within South Essex Partnership Trust. Follow-up 
assessments were predominantly conducted by Jenny Cove (again with support from 
assistant psychologists) as Nicola Jacobi was no longer blind to participants’ group 
allocation. Nicola Jacobi conducted focus groups with carers who had attended the 
carer training programme. Scoring of assessment was evenly divided. Each trainee 
analysed the data related to their own thesis separately and independently wrote up 
their own thesis.  
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Appendix D 
Information Sheets: 
 
1. People with Dementia  
2. Carers 
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PARTICIPANT INFORMATION SHEET 
 
 
Pilot study examining the effectiveness of weekly Cognitive Stimulation Therapy 
(CST) and the additional impact for people with dementia and their carers  
of including carer training in CST 
 
Invitation to participate in a research study 
You are being invited to take part in a research study. Before you decide, it is 
important for you to understand why the research is being done and what it will 
involve. Please take time to read the following information carefully and discuss it 
with others if you wish. Ask us if there is anything that is not clear or if you would 
like more information. Take time to decide whether or not you wish to take part.  
Thank you for reading this information sheet. 
 
What is the purpose of the study? 
In recent years, cognitive stimulation therapy (CST) groups have shown to be an 
enjoyable and beneficial therapy for people with memory problems. This project will 
show whether once weekly CST is effective.  
 
Often the carers of those taking part in CST groups request to have more 
involvement in the treatment so that they can understand the therapy being given and 
provide support to their relative/friend over the course of the group.  This project also 
aims to show how inclusion of a carer training programme affects the impact of CST 
for both the person attending CST and their carer. 
 
What happens in a cognitive stimulation therapy (CST) group? 
Traditionally CST groups are held as a 14 session programme, twice a week for 
seven weeks.  However, in practice NHS services tend to deliver CST once weekly 
for 14 weeks due to resource limitations.  The activities include for example multi-
sensory stimulation, word categorisation and discussion of current affairs.  The idea 
is to keep the mind active through enjoyable activities, undertaken as a structured 
programme facilitated by experienced and trained staff that will look after the group. 
The sessions include physical games, current affairs discussions, sounds, food, word 
games, and numbers games. 
 
Why have I been chosen? 
You have been invited to take part because you have at some point had a memory 
assessment. We need a large number of people with memory problems to help us 
evaluate the once weekly CST groups – 72 in total.  Each CST group may include up 
to 8 people.  
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Do I have to take part? 
It is up to you to decide whether or not to take part. If you do decide to take part you 
will be given this information sheet to keep and be asked to sign a consent form. If 
you decide to take part you are still free to withdraw at any time without giving a 
reason. A decision to withdraw at any time, or a decision not to take part, will not 
affect the standard of care you receive. 
 
What will happen to me if I take part? 
This study is a randomised trial. We need to have three groups so we can compare 
the outcomes for each group – a group in which people with dementia receive CST 
and their carers attend a carer training programme; a group in which people with 
dementia receive CST but their carers do no attend the carer training programme and 
a group in which people with dementia do not receive CST and their carers do not 
attend the carer training programme.  
 
Firstly we need to establish the effectiveness of weekly CST groups, and so we need 
to compare any changes experienced by people with dementia in CST groups with 
changes in people with dementia who have not received any treatment.   
 
Secondly we are exploring the impact on both people with dementia and their carers 
of adding a carer training programme to CST.  So we need to compare any changes 
experienced by people with dementia and their carer if the carer receives training 
with changes experienced by people with dementia and their carer if the carer does 
not receive training. The fairest way of doing this is to select people for each group 
by chance. The decision is made by an independent computer, which will not have 
any identifying information about you or your carer.   
 
If you decide to take part, your participation in the study will last for a time period of 
about four and a half months.  Following discussion of any questions you may have 
with a researcher, and signing the consent form, all participants will be asked to: 
 
1. Meet with a researcher for between an hour and an hour and a half to 
complete some questionnaires covering quality of life, cognition and your 
relationship with your carer. The time stated to complete the interviews and 
questionnaires is an estimate; you may take as many breaks as you want or 
feel necessary, and even complete the process over two sessions if preferred. 
 
2. To repeat these questionnaires with the researcher, after 15 weeks. 
 
Usually, the researcher will come to your home or the home of your relative/friend, 
but will be happy to meet you elsewhere if you would prefer. Usually, the researcher 
will meet with and interview your relative/friend at the same time as you are 
completing the questionnaires. Your answers to all the questions will be kept 
confidential and will not be disclosed to your relative/friend.   
 
Two thirds of participants entering the trial will be asked to attend CST once a week 
for fourteen weeks. The CST groups will include up to eight people and each session 
will last for about an hour.  They will be held in a suitable venue within your area 
and refreshments and transport will be arranged if needed.  Those allocated to CST 
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groups will be assessed in the two week period prior to the CST group starting and in 
the two week period following the end of the CST group. 
 
Those people allocated to the group with no CST (one third of participants) will be 
asked to complete the assessment immediately on entering the project.  They will 
complete a further assessment approximately 15 weeks later, and will then be offered 
the opportunity to attend the groups.  Therefore everyone who takes part in the 
research will receive the treatment.   
 
Expenses 
Any travel expenses incurred by yourself or your carer will be reimbursed. 
 
What do I have to do? 
Taking part in the study does not involve any lifestyle restrictions or changes. You 
can carry on your everyday activities as normal while participating in the study. All 
we ask is that you keep your appointments with us during the time that you are 
taking part. 
 
What are the possible disadvantages and risks of taking part? 
CST involves participating in a group programme that aims to be stimulating and 
enjoyable. Sessions involve discussing themes such as food, childhood and current 
affairs and the level of risk in taking part is therefore minimal. If the participant feels 
uncomfortable or distressed while taking part in a group, facilitators will be able to 
give additional one to one support if this is needed. 
 
What are the possible benefits of taking part? 
If you decide to take part, and are involved in the CST Groups we hope that this may 
be of some help to you, and previous group members have indeed reported that they 
have enjoyed the experience greatly. For all participants, the information we get from 
this study may help us to treat people with memory problems better in the future. 
 
Will my taking part in the study be kept confidential? 
We will ask for your permission to send your GP a letter explaining that you have 
agreed to take part in the study.  All information which is collected about you during 
the course of the study will be kept strictly confidential.  All data is stored without 
any identifying details under secure conditions. 
 
What will happen if I don’t want to carry on with the study? 
You will be free to withdraw from the study at any time, without giving a reason. 
Withdrawing from the study will not affect the standard of care you receive.  
 
What if something goes wrong? 
If you are harmed by taking part in this study, there are no special compensation 
arrangements. If you are harmed due to someone’s negligence, then you may have 
grounds for a legal action, but you may have to pay for your legal costs.  
 
Regardless of this, if you wish to make a complaint about any aspect of the way you 
have been approached or treated during the course of this study, the normal National 
Health Service complaints procedures should be available to you. If you are unhappy 
or dissatisfied about any aspect of your participation, we would ask you to tell us 
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about this in the first instance, so that we can try to resolve any concerns and find a 
solution. 
 
What will happen to the results of the research? 
The research is being carried out by two trainee psychologists as part of their 
Doctorate Training.  Nicola Jacobi is at City University London and undertaking a 
Doctorate in Counselling Psychology.  Jennifer Cove is at University College 
London (UCL) and undertaking a Doctorate in Clinical Psychology.   
 
Both will produce a research dissertation which forms as part of their final course 
assessment.  It will not be possible to identify individual results specifically, though a 
summary of the findings will be available if you are interested.   
 
Results will also be published in relevant journals. No participants will be identified 
in any publication arising from the study without their written consent. 
 
We will make arrangements for participants to be informed of the progress of the 
research and the results will be summarized in a document following the completion 
of the project.  Please let us know if you would like to receive a copy. 
 
Who has reviewed the study? 
All NHS research is looked at by an independent group of people, called a Research 
Ethics Committee to protect your safety, rights, well-being and dignity. This study 
has been reviewed and been given a favourable opinion by the London South East 
National Research Ethics Committee. 
 
Who can I contact for further information? 
For more information about this research, please contact: 
 
Dr Helen Donovan 
Consultant Clinical Psychologist 
Clinical Psychology Service, Gilbert Hitchcock House 
21 Kimbolton Road 
Bedford MK40 2AW 
 
Phone:   
Mobile:  
Email:    
 
Or if you have any complaints about this study please contact: 
Ruth Burrell, R&D Administrator 
R& D Department, Disability Resource Centre   
Poynters House, Poynters Road, 
Dunstable 
Bedfordshire, LU5 4TP 
 
Phone:  
Email:  
 
Thank you for considering taking part in this research study! 
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INFORMATION SHEET FOR CARERS 
 
 
Pilot study examining the effectiveness of weekly Cognitive Stimulation Therapy 
(CST) and the additional impact for people with dementia and their carers of 
including carer training in CST 
 
 
Invitation to participate in a research study 
You are being invited to take part in a research study. Before you decide, it is 
important for you to understand why the research is being done and what it will 
involve. Please take time to read the following information carefully and discuss it 
with others if you wish. Ask us if there is anything that is not clear or if you would 
like more information. Take time to decide whether or not you wish to take part.  
Thank you for reading this information sheet. 
 
What is the purpose of the study? 
In recent years, cognitive stimulation therapy (CST) groups have shown to be an 
enjoyable and beneficial therapy for people with memory problems. This project will 
show whether once weekly CST is effective.  
 
Often the carers of those taking part in CST groups request to have more 
involvement in the treatment so that they can understand the therapy being given and 
provide support to their relative/friend over the course of the group.  This project also 
aims to show how inclusion of a carer training programme affects the impact of CST 
for both the person attending CST and their carer. 
 
What happens in a cognitive stimulation group? 
Traditionally CST groups are held as a 14 session programme, twice a week for 
seven weeks.  However, in practice NHS services tend to deliver CST once weekly 
for 14 weeks due to resource limitations.  The activities include for example multi-
sensory stimulation, word categorisation and discussion of current affairs.  The idea 
is to keep the mind active through enjoyable activities, undertaken as a structured 
programme facilitated by experienced and trained staff that will look after the group. 
The sessions include physical games, current affairs discussions, sounds, food, word 
games, and numbers games. 
  
Why have I been chosen? 
You have been invited to take part because of your support for a person who at some 
point had a memory assessment.  We need a large number of people with memory 
problems to help us evaluate the weekly CST groups – 72 in total.  Each CST group 
may include up to 8 people.  In addition, we need each of them to have a carer who 
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has regular contact with them to evaluate impact of adding a carer training 
programme to CST for both the individual in the CST group and for their carer. 
 
Do I have to take part? 
It is up to you to decide whether or not to take part. If you do decide to take part you 
will be given this information sheet to keep and be asked to sign a consent form.  If 
you decide to take part you are still free to withdraw at any time without giving a 
reason.  A decision to withdraw at any time, or a decision not to take part, will not 
affect the standard of care your relative / friend receives. 
 
What will happen to me if I take part? 
This study is a randomised trial. We need to have three groups so we can compare 
the outcomes for each group – a group in which people with dementia receive CST 
and their carers attend a carer training programme; a group in which people with 
dementia receive CST but their carers do no attend the carer training programme and 
a group in which people with dementia do not receive CST and their carers do not 
attend the carer training programme.  
 
Firstly we need to establish the effectiveness of weekly CST groups, and so we need 
to compare any changes experienced by people with dementia in CST groups with 
changes in people with dementia who have not received any treatment.   
 
Secondly we are exploring the impact on both people with dementia and their carers 
of adding a carer training programme to CST.  So we need to compare any changes 
experienced by carers and people with dementia if the carer receives training with 
changes experienced by carers and people with dementia if the carer does not receive 
training. The fairest way of doing this is to select people (the person with dementia 
and their carer) for each group by chance. The decision is made by an independent 
computer, which will not have any identifying information about you or your 
relative/friend.   
 
Those people allocated to the group for which the person with dementia does not 
receive CST and their carer does not receive training will be asked to complete the 
interviews described below immediately on entering the project and then after 15 
weeks.  Your friend/relative will be invited to attend a CST group following their 
involvement in the research project. 
 
Those allocated to a group in which the person with dementia will receive CST will 
be interviewed in the two week period prior to the CST group starting and in the two 
week period following the end of the CST group. 
 
If you decide to take part, your participation in the study will last for a time period of 
approximately four and half months.  Following discussion of any questions you may 
have with a researcher, and signing the consent form, all participants will be asked 
to: 
 
1. Meet with a researcher for between an hour and an hour and a half to 
complete some questionnaires.  Your relative/friend’s questionnaires will 
cover their cognitive abilities, and their perception about the quality of their 
life.  The questionnaires you will be asked to complete will be about your 
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general health, your feelings of self-efficacy, satisfaction and burden.  Both 
of you will be asked to complete a questionnaire about the quality of your 
relationship.  The time stated to complete the interviews and questionnaires is 
an estimate; you and your friend/relative may take as many breaks as you 
want or feel necessary, and even complete the process over two sessions if 
preferred. 
 
2. To repeat these questionnaires with the researcher, after 15 weeks 
 
3. Usually, the researcher will come to your home or the home of your 
relative/friend if you live separately, but will be happy to meet you elsewhere 
if you would prefer. Usually, the researcher will meet with and interview 
your relative/friend at the same time as you are completing the questionnaires.  
Your answers to all the questions will be kept confidential and will not be 
disclosed to your relative/friend.   
 
Carers allocated to receive carer training (one third of carers) will be also be asked 
to: 
  
1. Attend two training sessions 
 
a. The first session will be held at the time the person you care for 
begins their CST group. This session will last for half a day and 
introduce you to the key principles of CST and explore ways for you 
to engage in activities at home based on these principles.  
 
b. The second session will be held around the time the person you care 
for finishes their CST group. This session will last for approximately 
an hour with a focus on maintaining the ideas from the first session 
into the future.  
 
c. An optional third session will be offered mid-way through the CST 
sessions. This session will be one hour long and offer you the 
opportunity to come and discuss any difficulties you are having and 
get advice if you need it.  
 
2. To complete a weekly diary reflecting on your thoughts and the activities 
undertaken.  You will be asked to undertake activities as directed in the first 
training session at least three times a week 
 
3. Participate in either a focus group or an individual interview in order to 
explore in more depth your experience of undertaking the carer training 
programme. Focus groups/individual interviews will last approximately an 
hour, during which time you will be asked to reflect on your experiences of 
the carer training programme. An experienced researcher will lead the focus 
groups or interviews. 
 
The focus groups will be audio recorded in a digital recording format.  You 
will not be identified in the recording.  The recordings will be encrypted and 
password protected and kept on a secure server of the Sponsor organisation 
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(SEPT NHS Trust).  They will be retained as research data for a period of 7 
years after which time they will be permanently deleted. 
 
4. Refreshments will be provided and transport arranged as needed. Suitable 
breaks will be scheduled into all groups. Carer training sessions will be led by 
skilled and trained members of staff who receive regular support and 
supervision. 
 
5. Those carers who do not get allocated to the carer training programme as part 
of the research will have an opportunity to undertake some training in CST 
principles and activities after their involvement in the research has finished.  
This will be completely voluntary. 
 
Expenses 
Any travel expenses incurred by you or your relative/friend will be reimbursed. 
 
What do I have to do? 
Taking part in the study does not involve any lifestyle restrictions or changes either 
for you or your friend, relative. You can carry on your everyday activities as normal 
while participating in the study.  
 
What if my relative/friend is unable to consent to take part, or loses the ability 
to consent? 
All participants in research are invited to complete a consent form before the 
research commences. Sometimes people with memory problems are unable to make 
a decision to consent to a research project because they have difficulty in 
understanding or retaining the information provided about the project. Sometimes 
people with memory problems are able to do this at the beginning of the project, but 
later may not be able to provide their consent. In either of these circumstances, the 
research team is required to consult with someone who is involved in the person’s 
care, such as a family member, regarding whether the person should participate, or 
continue to participate, in the project.  If concerns do arise regarding the your 
relatives’/friends’ ability to consent, we would seek your advice regarding whether 
the person with memory problems should participate and what you think the person’s 
feelings and wishes would be regarding taking part. If the person has previously 
made an advance statement or advanced decision that is relevant, we would not do 
anything to go against this. 
 
What are the possible disadvantages and risks of taking part? 
You may feel that the requirements of your participation appear onerous and time 
consuming.  However, the CST carer training programme has been designed with 
input from other carers whose family member have been through CST and is based 
around what they feel they would have liked to receive.  Meetings and training 
sessions will be organized as far as possible to fit around your own commitments. 
 
For your relative/friend CST involves participating in a group programme that aims 
to be stimulating and enjoyable. Sessions involve discussing themes such as food, 
childhood and current affairs and it the level of risk in taking part is therefore 
minimal. If while taking part the participant feels uncomfortable or distressed while 
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taking part in a group, facilitators will be able to give additional one to one support if 
this is needed  
 
What are the possible benefits of taking part? 
If you decide to take part you will receive training which will provide you with a 
greater understanding of the treatment your relative/friend is involved in, peer 
support and new communication skills. 
 
We hope that your relative/friend being involved in the CST groups will be of some 
help to them, and previous group members have indeed reported that they have 
enjoyed the experience greatly. For all participants, the information we get from this 
study may help us to treat people with memory problems better in the future. 
 
Will my taking part in the study be kept confidential? 
We will request permission to send the person with memory problem's GP a letter 
explaining that you have both agreed to take part in the study.  Otherwise, all 
information collected about you during the course of the study will be kept strictly 
confidential. All data is stored without any identifying details under secure 
conditions. 
 
What will happen if I don’t want to carry on with the study? 
You and your relative/friend will be free to withdraw from the study at any time, 
without giving a reason. Withdrawing from the study will not affect the standard of 
care your relative/friend receives.  We will need to use any data collected in the 
study up to the point of withdrawal. 
 
What if something goes wrong? 
If you are harmed by taking part in this study, there are no special compensation 
arrangements. If you are harmed due to someone’s negligence, then you may have 
grounds for a legal action, but you may have to pay for your legal costs.  Regardless 
of this, if you wish to make a complaint about any aspect of the way you have been 
approached or treated during the course of this study, the normal National Health 
Service complaints procedures should be available to you. If you are unhappy or 
dissatisfied about any aspect of your participation, we would ask you to tell us about 
this in the first instance, so that we can try to resolve any concerns and find a 
solution. 
 
What will happen to the results of the research? 
The research is being carried out by two trainee psychologists as part of their 
Doctorate Training.  Nicola Jacobi is at City University London and undertaking a 
Doctorate in Counselling Psychology.  Jennifer Cove is at University College 
London (UCL) and undertaking a Doctorate in Clinical Psychology.  Both will 
produce a research dissertation which forms as part of their final course assessment.  
It will not be possible to identify individual results specifically, though a summary of 
the findings will be available if you are interested.   
 
Results will also be published in relevant journals. No participants will be identified 
in any publication arising from the study without their written consent. 
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We will make arrangements for participants to be informed of the progress of the 
research and the results will be summarized in a document following the completion 
of the project.  Please let us know if you would like to receive a copy. 
 
Who has reviewed the study? 
All NHS research is looked at by an independent group of people, called a Research 
Ethics Committee to protect your safety, rights, well-being and dignity. This study 
has been reviewed and been given a favourable opinion by the London South East 
National Research Ethics Committee. 
 
Who can I contact for further information? 
For more information about this research, please contact the Chief Investigator: 
 
Dr Helen Donovan 
Clinical Psychology Service, Gilbert Hitchcock House 
21 Kimbolton Road 
Bedford MK40 2AW 
 
Phone:   
Mobile:  
Email:    
 
Or if you have any complaints about this study please contact: 
 
Ruth Burrell, R&D Administrator 
R& D Department, Disability Resource Centre   
Poynters House, Poynters Road, 
Dunstable 
Bedfordshire, LU5 4TP 
 
Phone:  
Email:  
 
Thank you for considering taking part in this research study! 
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Appendix E 
Consent Forms: 
 
1. People with Dementia  
2. Carers 
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Participant Consent Form 
 
Participant Identification Number for this trial ____________________ 
 
 
Pilot study examining the effectiveness of weekly Cognitive Stimulation Therapy (CST) 
and the additional impact for people with dementia and their carers  
of including carer training in CST 
 
 
Name of Researcher:…………………………………..                 Please Initial Boxes 
 
 
1. I confirm that I have read and understand the participant  
information sheet (Version 2 - 09.05.2012) for the above study 
and have had the opportunity to ask questions. 
 
 
2. I understand that my participation is voluntary and that I am  
free to withdraw at any time, without giving any reason, 
without the medical care or legal rights of myself or my relative 
being affected. 
 
 
 
3. I give permission for my GP to be informed of my participation 
in the study. 
 
 
 
4. I understand that all information given by me or about  
      me will be treated as confidential by the research team. 
            
 
 
 
 
5. I agree to take part in the above study.                                       
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Name of Participant                     Date                                 Signature 
 
 
_____________________             ____________                ___________________ 
 
 
 
Name of Person taking consent      Date                                 Signature 
(if different from the researcher) 
 
 
_____________________              ____________                ___________________ 
 
 
 
 
Researcher                                    Date  Signature 
 
 
_____________________              _____________              ____________________ 
 
 
 
 
 Name of Carer                             Date                                 Signature 
 
 
_____________________             ____________                ___________________ 
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Carer Participant Consent Form  
 
Participant Identification Number for this trial ____________________ 
 
 
Pilot study examining the effectiveness of weekly Cognitive Stimulation Therapy 
(CST) and the additional impact for people with dementia and their carers  
of including carer training in CST 
 
 
Name of Researcher:…………………………………..                 Please Initial 
Boxes 
 
 
1. I confirm that I have read and understand the information  
sheet for carers (Version 2 - 09.05.2012) for the above study and  
have had the opportunity to ask questions. 
 
 
2. I understand that my participation is voluntary and that I am  
free to withdraw at any time, without giving any reason, 
without the medical care or legal rights of myself or my relative 
being affected. 
 
 
3. I give permission for my relative’s GP to be informed of our  
participation in the study. 
 
 
 
4. I have been consulted regarding the participation of my relative,  
as required by the Mental Capacity Act, and I believe they would  
wish to take part / continue to take part in the study. 
 
 
            
5. I understand that all information given by me or about me or my  
relative will be treated as confidential by the research team. 
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6. I agree to take part in the above study with my relative.            
 
 
 
 
 
Name of Participant                       Date                                 Signature 
 
 
_____________________             ____________                __________________ 
 
 
 
Name of relative 
 
 
_____________________          
 
 
 
 
Name of Person taking consent       Date                                 Signature 
(if different from the researcher) 
 
 
_____________________              ____________                _________________ 
 
 
 
Researcher                                      Date                                 Signature 
 
 
_____________________              _____________              _________________ 
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Appendix F 
Letter for General Practitioner 
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        Clinical Psychology Service 
        Gilbert Hitchcock House 
        21 Kimbolton Road 
        MK40 2AW 
        Tel:  
        Fax:  
[GP Address] 
[DATE] 
 
GENERAL PRACTITIONER INFORMATION SHEET 
 
 
Title: Pilot study examining the effectiveness of weekly Cognitive Stimulation Therapy 
(CST) and the additional impact for people with dementia and their carers of including 
carer training in CST 
 
 
 
…………………………….. (Dob)……….. has been invited and consented to take part 
in a research study.  Please let us know if there is anything that is not clear, or if you would 
like more information.  
 
Dr Gary Kupshik is the sponsor for this project from South Essex Partnership University 
NHS Foundation Trust (SEPT). The project is being run across a number of sites, including 
Bedfordshire and Camden and Islington.  Dr Helen Donovan is co-ordinating the trial in the 
Bedfordshire area and Dr Joshua Stott is co-ordinating the trial in the Camden and Islington 
area. 
 
Cognitive Stimulation Therapy (CST) groups are an enjoyable and beneficial therapy for 
people with memory problems. The idea is to keep the mind active through enjoyable 
activities, which are undertaken as a structured programme facilitated by experienced and 
trained staff.  The activities include multi-sensory stimulation, for example: physical games, 
discussion of current affairs, sounds, food, word and number games.  Traditionally CST 
groups are held as a 14 session programme twice a week for seven weeks.  
 
This study aims to show whether weekly CST (14 sessions once weekly for 14 weeks) is 
effective and whether adding a carer training programme to CST has an impact on the well-
being of people with dementia and their carers.. 
 
We are interested in including people with any type of dementia.  We will interview them 
and their carer who has also agreed to take part in the study at the start of their involvement 
with the project and after 15 weeks. 
 
The interviews will use outcome measure which will evaluate: 
 
 Quality-of-life  
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 Cognition 
 Quality of patient-carer relationship 
 
 
Interviews will also collect information about: 
 
 Personal details (age, relationship, educational level, etc.)  
 
 
The study will not affect your patient’s current or future treatment. 
  
The results of this study are expected to be published in relevant journals and at conferences. 
All interviews are confidential and will not be disclosed to anyone else. The information 
collected in the study will be anonymous and patients will not be identified in any 
report/publication. 
 
All proposals for research using human subjects are reviewed by the local Ethics Committee 
before they can proceed and the appropriate permission. 
 
Thank you for reading this information sheet.  Please do not hesitate to contact Dr Helen 
Donovan if you need any further information. 
 
 
Kind regards, 
 
 
[name of member of research team] 
 
134 
 
 
Appendix G 
List of Themes of CST Groups 
 
CST sessions followed one of 14 general themes: 
1. Physical games 
2. Sound 
3. Childhood 
4. Food 
5. Current affairs 
6. Faces / scenes 
7. Word association 
8. Being creative 
9. Categorising objects 
10. Orientation 
11. Using money 
12. Number games 
13. Word games 
14. Team quiz 
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Appendix H 
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